ENDOCYTOSIS is a key mechanism that regulates plasma membrane composition and thus fundamentally supports cellular physiology and homeostasis. It is the process by which cells collect extracellular material and plasma membrane-associated surface proteins, such as receptors, channels, and signaling proteins, and package them into vesicles that are pinched off and enter the cytosol ([Figure 1](#fig1){ref-type="fig"}). Internalized vesicles then fuse with other internal compartments so that their contents can be recycled or degraded.

![Stages of endocytic patch initiation, maturation, and turnover. The stages of progression (numbered 1--9) of an endocytic patch from initiation to membrane invagination, followed by scission and disassembly/uncoating, make components available for new rounds of patch formation (recycling). Boxes describe the concurrent sequential behavior of the actin cytoskeleton and actin-associated proteins during this process. Each icon represents a group of proteins with related functions, activities, and/or localization.](315fig1){#fig1}

In most steps of intracellular traffic, including endocytosis, proteins (referred to as "cargo") move between intracellular organelles and the extracellular milieu via formation of vesicles or tubules. This process begins when transmembrane cargo recruit cytosolic proteins to the membrane surface. These proteins then assemble in a temporally ordered pattern suggesting layers or coats ([Figure 1](#fig1){ref-type="fig"}). The inner "adaptor" layer of coat proteins binds to sorting signals in the cytosolic portions of the transmembrane cargo proteins to collect and concentrate the cargo and also helps to recruit and organize subsequent outer coat layers. Among the earliest proteins recruited to sites of vesicle formation are the namesake "coat" proteins (*e.g.*, clathrin, COPI, COPII), which polymerize into spherical cages of different sizes to promote vesicle budding. A final set of components acts on the membrane itself to facilitate scission and release of the vesicle into the cytosol ([Figure 1](#fig1){ref-type="fig"}).

Clathrin-mediated endocytosis (CME) is the best characterized of all the endocytic pathways and requires a large number of cytosolic proteins that concentrate transmembrane cargo proteins and form clathrin-coated vesicles ([@bib243]). In CME, adaptor proteins recognize sorting signals in the cargo proteins and directly link the cargo to clathrin. The basic subunit of clathrin is a triskelion, which is a trimer of clathrin heavy chains, each with an associated clathrin light chain. The controlled formation of a dense and branched actin-filament network provides forces critical for driving subsequent membrane tubulation and vesicle scission ([Figure 1](#fig1){ref-type="fig"}). Although there is an absolute requirement for dynamic rearrangements of the actin cytoskeleton to support CME in yeast, there is a more variable requirement in animal cells, discussed below.

Our goal in this review is to summarize the current understanding of endocytosis and its relationship with actin dynamics in budding yeast, while highlighting the major advances that have been made since publication of chapters on this topic in the last edition of the *YeastBook* ([@bib42]; [@bib188]), and finally to point out some of the remaining open questions in this field. We hope that this information will be useful to newcomers and experts alike and to those not directly working on endocytosis or actin biology. Looking back, it becomes strikingly evident that in 1997 our knowledge was in its infancy and that major leaps have since been made in our understanding of actin and endocytosis. There is now a wealth of information on the \>50 components of endocytic sites, the temporal order of their arrival, their biochemical activities, physical interactions, and relative abundances, along with recent ultrastructural analysis clarifying the successive steps in endocytic internalization of vesicles from the plasma membrane. While much of this work was initially pioneered in *Saccharomyces cerevisiae*, many critical insights as well as important quantitative information (*e.g.*, numbers of molecules per actin patch and mathematical modeling of actin networks; see below) have been contributed by studies in *Schizosaccharomyces pombe* (*e.g.*, [@bib32]; [@bib340]; [@bib14]). We attempt to compile all of this information together into a working model for the formation and internalization of endocytic vesicles. We apologize to all those whose work we did not highlight. Even in a review of this length, it was not possible to discuss this subject and its literature base comprehensively, and we were faced with difficult choices regarding where to focus. However, we refer readers to a series of excellent recent reviews on actin and endocytosis that provide complementary information and more in-depth discussion of specific areas that we do not ([@bib41]; [@bib258]; [@bib398]; [@bib181]; [@bib333]).

Cortical actin patches represent the final stages of endocytic internalization {#s2}
==============================================================================

It is now clear that the plasma membrane-associated structures referred to as "cortical actin patches" correspond to sites of endocytosis in the late (actin-dependent) stages of vesicle formation. However, in 1997, the equivalency of actin patches to endocytic sites had not yet been established. A few proteins genetically linked to endocytosis and actin were known to localize to cortical sites on the plasma membrane (*e.g.*, [Abp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000684) and [Sac6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002536)) ([@bib96]), and immuno-electron microscopy (immuno-EM) had suggested an association between these proteins and membrane invaginations ([Figure 3, A and B](#fig3){ref-type="fig"}), leading to preliminary models for how actin might contribute to endocytosis ([@bib262]) ([Figure 3C](#fig3){ref-type="fig"}). However at the time, there was minimal understanding of the ultrastructure, dynamics, or function of these actin structures.

An important breakthrough came in 1996, when two studies used live-cell imaging with green fluorescent protein (GFP) fusions to study actin patch dynamics ([@bib94]; [@bib392]). Both groups concluded that cortical actin patches move within the plane of the membrane, in some cases for long distances. It was suggested that individual patches might assemble *de novo* and later disassemble, but it was difficult to gather further evidence for this model, given technological limitations; *e.g.*, the intervals in time-lapse imaging were too long to permit accurate tracking of individual actin patches. These early studies set the stage for subsequent paradigm-shifting discoveries, in which two-color live-cell imaging of pairs of cortical patch components revealed that endocytic and actin machinery colocalize but arrive at sites of endocytosis at different times ([@bib189]). It remained unclear though, how actin assembly was initiated at endocytic sites and how actin organization and dynamics were controlled. Efforts to connect actin with endocytosis were further confounded by unresolved differences in the molecular requirements for animal *vs.* yeast endocytosis, including inconsistent requirements for clathrin, the scission-promoting GTPase dynamin, and actin itself.

Genetic screens for endocytosis mutants {#s3}
=======================================

An obvious strength of the yeast system is the ability to conduct forward genetic screens to identify the genes involved in a cellular process. Depending on how the screen is performed, different types of genes will be identified while others will be missed (*e.g.*, redundant gene pairs). A wide variety of genetic screens designed to identify factors important for endocytosis have been conducted over the years, with a subset of factors being found in more than one screen ([Table 1](#t1){ref-type="table"}). These screens have provided the platform for many subsequent reverse genetic and biochemical studies dissecting the roles of candidate genes/proteins in endocytosis and defining their physical and genetic interaction partners. Together, these approaches have yielded a rich set of information on the endocytic machinery in budding yeast ([Table 2](#t2){ref-type="table"}). Below, we describe several of the early studies that identified endocytic factors, which illustrates the value in performing a variety of different genetic screens to probe a single process.

###### Genes identified in screens for endocytosis mutants

  Gene                                                                                                                        Official name:   Also known as                                         Screen                                                Reference                                 
  --------------------------------------------------------------------------------------------------------------------------- ---------------- ----------------------------------------------------- ----------------------------------------------------- ----------------------------------------- -----------
  *END1*                                                                                                                      *PEP5*           *VAM1*, *VPL9*, *VPS11*, *VPT11*, *YMR231w*           Lucifer yellow internalization defect                 [@bib73]                                  
  *END2*                                                                                                                      *GAA1*           *YLR088w*                                             (EMS mutagenesis)                                                                               
  *END3*                                                                                                                      *END3*           *YNL084c*                                             α-Factor uptake defect                                [@bib314]                                 
  *END4*                                                                                                                      *SLA2*           *MOP2*, *YNL243w*, *RCB432*                           (EMS mutagenesis)                                                                               
  *END5*                                                                                                                      *VRP1*           *MDP2*, *YLR337w*                                                                                           [@bib266]                                 
  *END6*                                                                                                                      *RVS161*         *FUS7*, *SPE161*, *YCR009c*                                                                                                                           
  *END7*                                                                                                                      *ACT1*           *ABY1*, *YFL039c*                                                                                                                                     
  *END8*                                                                                                                      *LCB1*           *TSC2*, *YMR296c*                                     Synthetic lethal with V-ATPase mutation               [@bib265]                                 
  *END9*                                                                                                                      *ARC35*          *YNR035c*                                             (EMS mutagenesis)                                                                               
  *END10*                                                                                                                     Unknown          Unknown                                                                                                                                               
  *END11*                                                                                                                     *ERG2*           *YMR202w*                                                                                                                                             
  *END12*                                                                                                                     *VPS34*          *PEP15*, *VPL7*, *VPT29*, *STT8*, *VPS7*, *YLR240w*                                                                                                   
  *END13*                                                                                                                     *VPS4*           *CSC1*, *GRD13*, *VPL4*, *VPT10*, *DID6*, *YPR173c*                                                                                                   
  *DIM1*                                                                                                                      *SHE4*           *YOR035c*                                             FM4-64 uptake defect                                  [@bib406]                                 
  *DIM2*                                                                                                                      *PAN1*           *MDP3*, *MIP3*, *YIR006c*                             (EMS mutagenesis)                                                                               
  *DIM4*                                                                                                                      *FAB1*           *SVL7*, *YFR019w*                                                                                           [@bib337]                                 
  *SYS1*                                                                                                                      *SYS1*           *YJL004c*                                             Reduced Lucifer Yellow accumulation                   [@bib411]                                 
  *YNL177c*                                                                                                                   *MRPL22*         *YNL177c*                                             (Nonessential gene deletion collection)                                                         
  *YNL227c*                                                                                                                   *JJJ1*           *YNL227c*                                                                                                                                             
  *EDE1*                                                                                                                      *EDE1*           *BUD15*, *YBL047c*                                                                                                                                    
  *TLG2*                                                                                                                      *TLG2*           *YOL018c*                                                                                                                                             
  *RCY1*                                                                                                                      *RCY1*           *YJL204c*                                                                                                                                             
  *YNR075w*                                                                                                                   *COS10*          *YNR075w*                                                                                                                                             
  *SDS24*                                                                                                                     *SDS24*          *YBR214w*                                                                                                                                             
  *YDR036c*                                                                                                                   *EHD3*           *YDR036c*                                                                                                                                             
  *FTH1*                                                                                                                      *FTH1*           *YBR207w*                                                                                                                                             
  *YBR266c*                                                                                                                   *REI1?*          *YBR267w? (YBR266c =* dubious ORF*)*                                                                                                                  
  *YDL231c*                                                                                                                   *BRE4*           *YDL231c*                                                                                                                                             
  *YNL297c*                                                                                                                   *MON2*           *YSL2*, *YNL297c*                                                                                                                                     
  *VPS53*                                                                                                                     *VPS53*          *YJL029c*                                                                                                                                             
  *YPK1*                                                                                                                      *YPK1*           *SLI2*, *YKL126w*                                     Ubiquitin-dependent internalization of alpha-factor   [@bib87]                                  
  *TOR2*                                                                                                                      *TOR2*           *DRR2*, *YKL203c*                                     (EMS mutagenesis of strain with Ste2-378Stop)         [@bib88]                                  
                                                                                                                                                                                                                                                                                                     
  A partial list of hits from the screen (only genes predicted to be involved in endocytosis)                                                                                                                                                                                                        
  Gene                                                                                                                        Official name    Also known as                                         Rank                                                  Screen                                    Reference
  *RVS161*                                                                                                                    *RVS161*         *END6*, *FUS7*, *SPE161*, *YCR009c*                   1                                                     Elevated Snc1 levels at plasma membrane   [@bib51]
  *VRP1*                                                                                                                      *VRP1*           *END5*, *MDP2*, *YLR337w*                             4                                                     (Nonessential gene deletion collection)   
  *RVS167*                                                                                                                    RVS167           *YDR388w*                                             8                                                                                               
  *LDB17*                                                                                                                     *LDB17*          *YDL146w*                                             10                                                                                              
  *SLA1*                                                                                                                      *SLA1*           *YBL007c*                                             12                                                                                              
  *ARC18*                                                                                                                     *ARC18*          *YLR370c*                                             18                                                                                              
  *YAP1801*                                                                                                                   *YAP1801*        *YHR161c*                                             29                                                                                              
  *EDE1*                                                                                                                      *EDE1*           *BUD15*, *YBL047c*                                    31                                                                                              
  *YAP1802*                                                                                                                   *YAP1802*        *YGR241c*                                             42                                                                                              
  *CAP1*                                                                                                                      *CAP1*           *YKL007w*                                             45                                                                                              
  *TPM1*                                                                                                                      *TPM1*           *YNL079c*                                             52                                                                                              
  *ABP1*                                                                                                                      *ABP1*           *YCR088w*                                             54                                                                                              
  *MYO5*                                                                                                                      *MYO5*           *YMR109w*                                             61                                                                                              
  *INP52*                                                                                                                     *INP52*          *SJL2*, *YNL106c*                                     68                                                                                              
  *AIM21*                                                                                                                     *AIM21*          *YIR003w*                                             78                                                                                              
  *CAP2*                                                                                                                      *CAP2*           *YIL034c*                                             127                                                                                             
  *TWF1*                                                                                                                      *TWF1*           *YGR080w*                                             155                                                                                             
  *SAC6*                                                                                                                      *SAC6*           *ABP67*, *YDR129c*                                    209                                                                                             
  *SYP1*                                                                                                                      *SYP1*           *YCR030c*, *YCR029c-A*                                216                                                                                             
  *BBC1*                                                                                                                      *BBC1*           *MTI1*, *YJL021c*                                     231                                                                                             
  *ENT1*                                                                                                                      *ENT1*           *YDL161w*                                             281                                                                                             
  *END3*                                                                                                                      *END3*           *YNL084c*                                             315                                                                                             
  *LSB3*                                                                                                                      *LSB3*           *YFR024c-A*, *YFR024c*                                338                                                                                             
  *CRN1*                                                                                                                      *CRN1*           *YLR429w*                                             365                                                                                             
  *AIP1*                                                                                                                      *AIP1*           *YMR092c*                                             368                                                                                             
  *BZZ1*                                                                                                                      *BZZ1*           *LSB7*, *YHR114w*                                     383                                                                                             
  *PKH2*                                                                                                                      *PKH2*           *YOL100w*                                             396                                                                                             
  A partial list of hits from the screen (only those genes associated with endocytosis based on gene ontology are included)                                                                                                                                                                          
  *APL1*                                                                                                                      *APL1*           *YAP80*, *YJR005w*                                    Killer toxin resistance                               [@bib57]                                  
  *APL3*                                                                                                                      *APL3*           *YBL037w*                                             (Nonessential gene deletion + ts allele collection)                                             
  *APM4*                                                                                                                      *APM4*           *AMP1*, *YOL062c*                                                                                                                                     
  *APS2*                                                                                                                      *APS2*           *YAP17*, *YJR058c*                                                                                                                                    
  *EDE1*                                                                                                                      *EDE1*           *BUD15*, *YBL047c*                                                                                                                                    
  *SLA1*                                                                                                                      *SLA1*           *YBL007c*                                                                                                                                             
  *SLA2*                                                                                                                      *SLA2*           *END4*, *MOP2*, *YNL243w*, *RCB432*                                                                                                                   
  *END3*                                                                                                                      *END3*           *YNL084c*                                                                                                                                             
  *SHE4*                                                                                                                      *SHE4*           *DIM1*, *YOR035c*                                                                                                                                     
  *VRP1*                                                                                                                      *VRP1*           *END5*, *MDP2*, *YLR337w*                                                                                                                             
  *MYO5*                                                                                                                      *MYO5*           *YMR109w*                                                                                                                                             
  *ABP1*                                                                                                                      *ABP1*           *YCR088w*                                                                                                                                             
  *ARC18*                                                                                                                     *ARC18*          *YLR370c*                                                                                                                                             
  *SAC6*                                                                                                                      *SAC6*           *ABP67*, *YDR129c*                                                                                                                                    
  *RVS161*                                                                                                                    *RVS161*         *END6*, *FUS7*, *SPE161*, *YCR009c*                                                                                                                   
  *RVS167*                                                                                                                    *RVS167*         *YDR388w*                                                                                                                                             
  *APP1*                                                                                                                      *APP1*           *YNL094w*                                                                                                                                             
  *SRV2*                                                                                                                      *SRV2*           *CAP*, *YNL138w*                                                                                                                                      
  *DRS2*                                                                                                                      *DRS2*           *FUN38*, *SWA3*, *YAL026c*                                                                                                                            
  *YPK1*                                                                                                                      *YPK1*           *SLI2*, *YKL126w*                                                                                                                                     
  *ARV1*                                                                                                                      *ARV1*           *YLR242c*                                                                                                                                             

###### Yeast endocytosis proteins, partners, domains and mammalian homologs

  Yeast protein                              Physical interaction partners                          Key domains, *motifs*                Homolog, common name[*^a^*](#t2n1){ref-type="table-fn"}
  ------------------------------------------ ------------------------------------------------------ ------------------------------------ ---------------------------------------------------------
  Early coat proteins                                                                                                                    
  Ede1                                       Syp1, Yap1801/2, Ent1/2                                EH, CC, UBA                          Eps15
  Syp1                                       Ede1                                                   F-BAR, µHD, PRD                      FCHO1/2
  Chc1                                       Clc1, Yap1801/2, Ent1/2, Sla1                          β-propeller                          Clathrin heavy chain
  Clc1                                       Chc1, Sla2                                                                                  Clathrin light chain
  Pal1                                       Ede1                                                   NPF                                  Unknown
  Apl1                                       Apl3, Apm4, Aps2                                                                            AP2 complex β2 subunit
  Apl3                                       Apl1, Apm4, Aps2                                                                            AP2 complex α subunit
  Apm4                                       Apl1, Apl3, Aps2                                       µ                                    AP2 complex μ2 subunit
  Aps2                                       Apl1, Apl3, Apm4                                                                            AP2 complex σ2 subunit
                                                                                                                                         
  Middle coat proteins                                                                                                                   
  Sla2                                       Sla1, End3, Pan1, Clc1, Act1                           ANTH, CC, THATCH                     Hip1R, Hip1
  Yap1801, Yap1802                           Pan1, Ede1, Chc1                                       ANTH, *NPF*, *CBM*                   CALM, AP180
  Ent1, Ent2                                 Pan1, Ede1, Chc1, ubiquitin                            ENTH, *UIM*, *NPF*, *CBM*            Epsin
                                                                                                                                         
  Late coat proteins                                                                                                                     
  Sla1                                       Pan1, End3, Sla2, Chc1, Scd5                           SH3, SHD1, SHD2, SR repeats, *CBM*   CIN85
  Pan1                                       Sla1, End3, Sla2, Yap1801/2, Ent1/2, Myo3/5, Scd5      EH, CC, PRD, *WH2*, *acidic*         Intersectin
  End3                                       Sla1, Pan1, Scd5                                       EH, CC                               
  Lsb3                                       Las17, Ldb17                                           SH3                                  SH3YL1a
  Ysc84/Lsb4                                 Las17, Ldb17                                           SH3                                  SH3YL1a
  Lsb5                                       Sla1, Las17                                            VHS, GAT                             GGA?
                                                                                                                                         
  WASP/Myosin I                                                                                                                          
  Las17                                      Vrp1, Sla1, Bbc1, Syp1, Lsb1-5, Bzz1, Myo3/5, Rvs167   WH1/EVH1, PRD, *WH2*, *acidic*       WASP/N-WASP
  Vrp1                                       Las17, Myo3/5, Act1                                    PRD, *WH2*                           WIP (WASP interacting protein)
  Bzz1                                       Las17, Ldb17                                           F-BAR, SH3                           Syndapin
  Scd5                                       Glc7, Sla1, End3, Pan1                                                                      Unknown
  Myo3, Myo5                                 Act1, Pan1, Cmd1, Pan1, Vrp1, Las17                    Motor, TH1, TH2, SH3, *acidic*       Type I Myosin
  Bbc1                                       Las17                                                  SH3, PRD                             Unknown
  Ldb17                                      Sla1, Bzz1, Lsb3, Ysc84/Lsb4, Bem1                     PRD                                  DIP/WISH/SPIN90
                                                                                                                                         
  Actin[*^b^*](#t2n2){ref-type="table-fn"}                                                                                               
  Act1                                                                                                                                   Actin
  Pfy1                                       Srv2, Bni1, Bnr1                                                                            Profilin
  Arp2, Arp3, Arc15/18/19/35/40              Las17, Myo3/5, Pan1, Abp1, Gmf1, Crn1                  ARP, β-propeller                     Arp2/3 complex
  Abp1                                       Arp2/3, Rvs167, Aim3, Srv2, Scp1, Ark1, Prk1, Sjl2     ADFH, SH3, PRD, *acidic*             ABP1
  Aim3                                       Abp1, Rvs167                                           PRD, *NPF*                           Unknown
  Srv2/CAP                                   Cof1, Pfy1, Abp1, Twf1, Aip1                           HFD, β-sheet, PRD, *WH2*             Cyclase associated protein
  Ark1, Prk1, Akl1                           Abp1                                                   Ser/Thr kinase, PRD                  AAK1, GAK
  Cap1, Cap2                                 Twf1                                                                                        Capping protein (αβ subunits)
  Sac6                                                                                              CH                                   Fimbrin
  Scp1                                       Abp1                                                   CH, PRD, *CLR*                       Calponin/Transgelin
  Abp140                                                                                                                                 Unknown
  Cof1                                       Srv2, Crn1, Aip1                                       ADFH                                 Cofilin
  Twf1                                       Cap1/2, Srv2                                           ADFH                                 Twinfilin
  Crn1                                       Arp2/3, Cof1                                           β-propeller, CC                      Coronin
  Gmf1                                       Arp2/3                                                 ADFH                                 GMF (glial maturation factor)
  Aip1                                       Cof1, Srv2                                             β-propeller                          Aip1
  *Scission*                                                                                                                             
  Rvs161                                     Rvs167                                                 N-BAR                                Amphiphysin
  Rvs167                                     Rvs161, Abp1, Las17                                    N-BAR, SH3                           Amphiphysin/endophilin
  Vps1                                       Sla1                                                   GTPase                               Dynamin
  Inp52/Sjl2                                 Abp1                                                   phosphatase XYZ                      Synaptojanin 1
                                                                                                                                         
  Less-well-characterized proteins                                                                                                       
  Lsb1                                       Las17                                                  SH3                                  
  Pin3/Lsb2                                                                                         SH3                                  
  Bsp1                                                                                                                                   Unknown
  Gts1                                                                                                                                   Unknown
  App1                                                                                                                                   Unknown
  Ypp1                                                                                                                                   
  Aim21                                                                                                                                  Unknown
  Swf1                                                                                                                                   Palmitoyl transferase 1

Any gene for which a clearly identifiable homolog is currently unknown is indicated as such, even if presently seems to be specific to fungi.

Act1 is not listed as a binding partner for proteins in this subsection.

The first set of endocytosis mutants came from a collection of temperature-sensitive yeast strains produced by random EMS mutagenesis. The Riezman lab initially tested this collection for strains deficient in uptake of the bulk fluid phase marker Lucifer Yellow, identifying the *[end1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004844)* and *[end2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004078)* mutants ([@bib73]); however, these mutations were later found to have no direct effect on the internalization process ([@bib98]; [@bib156]). After switching to measuring uptake of radiolabeled α-factor (a pheromone peptide secreted by yeast), the first *bona fide* yeast endocytosis mutants, *[end3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005028)* and *[end4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005187)*, were discovered from the same strain collection ([@bib314]). Further screening identified *[end5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004329)*, *[end6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000602)*, and *[end7](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001855)* ([@bib266]). Interestingly, *[end7](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001855)* is an allele of the *[ACT1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001855)* (actin) gene, which had been shown previously to be defective in endocytosis ([@bib206]). In addition, the proteins encoded by *[END3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005028)--[END7](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001855)* were later shown to localize to cortical actin patches ([@bib30]; [@bib381]; [@bib408]; [@bib177]).

Another screen for endocytosis mutants was based on the observation that strains carrying a deletion of a vacuolar ATPase subunit such as *[vma2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000331)∆* grow only on low-pH media. It was speculated that the vacuoles of these mutants become acidified via the endocytic pathway ([@bib273]), and the Riezman lab found that combining an *end* mutant with *[vma2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000331)∆* led to inviability (*i.e.*, synthetic lethality). By performing EMS mutagenesis in a *[vma2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000331)∆* background, they isolated *[end8](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004911)* through *[end13](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006377)* as synthetic lethal mutations ([@bib265]). The *[END9](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005318)* gene encodes a protein later recognized as the [Arc35](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005318) subunit of the Arp2/3 complex ([@bib234]; [@bib400]), the first hint that branched actin structures are important for endocytosis (see *Mechanisms of Actin Assembly and Turnover*). This screen also highlighted the critical importance of membrane composition, since it identified enzymes that are required for synthesizing both sphingolipids (*[END8](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004911)/[LCB1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004911)*) and the yeast cholesterol-like molecule ergosterol (*[END11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004815)/[ERG2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004815)*) (see *Vesicle Scission and Uncoating*).

A growing appreciation for the role of ubiquitin in endocytosis ([@bib391]) led the Hicke lab to modify the original screen of random mutants defective for radiolabeled α-factor uptake. They mutagenized a strain expressing an α-factor receptor that entirely relied upon ubiquitin modification for its internalization ([@bib369]) to find ubiquitin-dependent internalization (*udi*) mutants. This approach yielded protein kinases [Ypk1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001609) and [Tor2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001686), which turned out to be required for both ubiquitin-dependent and -independent receptor internalization ([@bib87]; [@bib88]; [@bib368]).

Another marker for endocytosis is the fluorescent lipophilic (membrane-binding) dye FM4-64, which can be used to trace the endocytic pathway from the plasma membrane through endosomes to the vacuole ([@bib388]). EMS-mutagenized cells were subjected to a pulse/chase labeling with FM4-64, followed by flow cytometry selection of "dim" cells that had internalized the least amount of dye. This screen yielded the myosin chaperone [She4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005561)/[Dim1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005561) and the EH domain scaffold protein [Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445)/[Dim2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445) ([@bib406]). A role for the lipid kinase [Fab1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001915) in late stages of the endocytic pathway was subsequently uncovered using the same approach ([@bib337]).

After the yeast genome was sequenced in 1996 ([@bib138]), a strain collection was generated with deletions of nonessential genes, which provided the yeast community with another valuable tool for identifying endocytosis mutants. For example, a subset of these nonessential deletion strains was tested for deficiency in Lucifer Yellow accumulation, which identified the endosomal F-Box protein [Rcy1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003740), among others ([@bib410]; [@bib411]). Further, the Conibear lab screened several different gene deletion collections for strains with elevated plasma membrane levels of the v-SNARE protein [Snc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000028) ([@bib51]), an endocytic cargo that must be included in the membranes of secretory/endocytic vesicles for their delivery and fusion to the subsequent compartment ([@bib153]). This approach uncovered many of the expected genes, validating the general strategy, and identified the SH3-domain protein [Ldb17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002305) as an endocytosis protein. It also revealed quantitative endocytic defects for mutants in a number of actin binding proteins that reside on actin patches but had not previously been linked functionally to endocytosis (*e.g.*, [Aip1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004698), [Crn1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004421), [Gmf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002470)). The Drubin lab then used a larger set of systematic gene deletions combined with temperature-sensitive alleles to screen for mutants that were resistant to the yeast killer toxin virus, some of which were resistant due to the inability to internalize the toxin ([@bib57]). While the toxin receptor remains undefined, an exciting discovery from this screen was a requirement for the yeast homolog of the AP-2 adaptor complex. Until this finding, an endocytic role for the yeast AP-2 complex had been lacking ([@bib176]; [@bib420]).

Through the combined efforts of many labs, genetic screens, interaction studies, and biochemical analyses have uncovered the existence of dozens of proteins involved in endocytosis. Subsequent experimentation has shown that these components are sequentially recruited as early, middle, and late coats, leading to the formation of a colossal molecular assemblage that culminates in a burst of F-actin polymerization and the reshaping of plasma membrane into a vesicle. This multistep process is depicted in [Figure 1](#fig1){ref-type="fig"} and described in more detail in *Cargo Selection and Coat Formation*, *Mechanisms of Actin Assembly and Turnover*, and *Vesicle Scission and Uncoating*.

Cargo Selection and Coat Formation {#s4}
==================================

Clathrin was linked to endocytosis in animal cells in 1975 ([@bib300]), but only in the last decade has a role for clathrin in yeast become fully accepted ([@bib190]; [@bib275]). Whether budding yeast had a CME pathway was initially fraught with controversy, beginning with confusion about the requirements of clathrin for viability. In one commonly used lab strain background, the clathrin heavy chain (*[CHC1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003174)*) gene was found to be essential, while in another it was nonessential. Although the viable clathrin deletion cells were extremely sick ([@bib218]; [@bib299]) they exhibited only partial endocytosis defects, retaining 30--50% uptake of mating pheromone ([@bib298]). Later, using a *[chc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003174)* temperature-sensitive allele, it became possible to acutely disrupt clathrin function, which led to reduced endocytosis within 2 min of temperature shift ([@bib363]). The chronic *[chc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003174)∆* and acute *chc1-ts* endocytosis defects were similar, indicating that clathrin might play a direct role in endocytic internalization in yeast.

Two other issues fueled suspicions about the importance of clathrin for yeast endocytosis. First, the prevailing view was that the endocytic mechanisms used in yeast were likely to differ significantly from those used in mammalian cells ([@bib18]), since actin had been so closely linked to yeast endocytosis while apparently playing only a minor or specialized role in mammalian cells ([@bib147]; [@bib118]). Second, the majority of clathrin in yeast cells had been localized to large, concentrated intracellular punctae that are likely Golgi associated, with no apparent localization at the cell surface ([@bib303]). These two observations, along with the incomplete block of internalization in clathrin mutants, led some investigators to argue against a direct role of clathrin in facilitating endocytosis in yeast.

Two key developments then led to the direct visualization of clathrin at the yeast plasma membrane. First, following on the pioneering work from the Keen and Almers labs ([@bib120]; [@bib248]), [@bib189] established the use of two-color live-cell imaging techniques in yeast to analyze the dynamics of pairs of components of cortical actin/endocytic patches. Through this approach, they made the landmark discovery that cortical patches form in discrete stages following a stereotypical, temporally ordered program in which endocytic components (including the clathrin heavy and light chains) are subsequently joined by actin and actin-associated proteins ([Figure 1](#fig1){ref-type="fig"}). Further, mutating the endocytic protein [Sla2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005187)/[End4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005187) led to aberrantly long actin "comet tails" at endocytic sites, which allowed the measurement of both the rate of actin turnover ([@bib189]) and the relative positions of key actin regulatory proteins within the actin networks, *i.e.*, at the front, at the rear, or evenly distributed ([@bib282]; [@bib127]; [@bib251]). Next, the Lemmon lab found that *[sla2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005187)∆* mutants and/or treatment with the actin depolymerizing drug Latrunculin-A stabilized clathrin at the plasma membrane. In contrast, they found that clathrin adaptor mutants (two epsins and two AP180 proteins) had significantly diminished clathrin accumulation at the plasma membrane ([@bib275]). These observations were supported by the use of total internal reflection fluorescence (TIRF) microscopy, which reduced the signal from bright clathrin-positive internal structures and revealed the existence of transient patches of plasma membrane-associated clathrin in wild-type cells. Importantly, these clathrin patches subsequently recruited [Abp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000684), a well-established component of both the endocytic machinery and actin cytoskeleton ([@bib275]). Thus, clathrin was finally accepted as an important and early arriving component of the endocytic machinery in yeast, and connected CME to the actin cytoskeleton.

Overview of the stages of yeast endocytosis {#s5}
-------------------------------------------

A major concept revealed by the above-mentioned studies and elaborated on in studies that followed was that an endocytic site develops or matures over time and that numerous proteins are sequentially recruited to this site and assembled into a structure that collects cargo and sculpts the plasma membrane into a vesicle. This process can be broadly divided, into three operational steps: (1) an immobile phase ([Figure 1](#fig1){ref-type="fig"}, steps 1--4; coat assembly), (2) a mobile phase ([Figure 1](#fig1){ref-type="fig"}, steps 5--7; actin assembly, membrane invagination, and vesicle scission), and (3) a patch dissolution phase ([Figure 1](#fig1){ref-type="fig"}, steps 8 and 9; vesicle uncoating and fusion with endosome). Note that uncoating of certain components may also be a prerequisite to scission.

For organizational purposes, the remainder of *Cargo Selection and Coat Formation* focuses on the immobile phase of patch assembly. We first discuss the selection of cargo proteins and then coat assembly ([Figure 1](#fig1){ref-type="fig"}, steps 1--4), including the recruitment and functions of early, middle, and late coat complexes. As discussed in detail below, the best-characterized adaptors are members of the middle and late coat complexes. In the process of these coat layers being recruited and ultimately forming a vesicle, the protein constituents form a dense network of interactions with each other, with the membrane, and with transmembrane cargo proteins, although there are undoubtedly more interactions to be defined ([Figure 2](#fig2){ref-type="fig"}). The coats both organize cargo and generate a structural platform to transmit forces generated by F-actin polymerization for vesicle formation, as described in *Mechanisms of Actin Assembly and Turnover* and *Vesicle Scission and Uncoating*.

![Endocytic adaptor and coat proteins. Depicted are the key factors in the three stages of endocytic coat formation, early, middle, and late coat proteins, which are recruited at distinct stages of endocytosis and thus represented as separate layers. Importantly, these represent temporal and not necessarily spatially segregated layers. Lines indicate known binding interactions among components. See *Cargo Selection and Coat Formation* for details. Domains abbreviations: LC, light chain; TD, terminal domain; EH, Eps15 homology domain; NPF, Asn--Pro--Phe motif; F-BAR, FER/Cip4 homology-Bin/Amphiphysin/Rvs domain; PP, polyproline region; µHD, µ homology domain; ENTH, Epsin N-terminal homology domain; CBM, clathrin-binding motif; ANTH, AP180 N-terminal homology domain; CC, coiled coil; THATCH, talin-HIP1/R/Sla2p actin-tethering C-terminal homology domain; V, verprolin homology motif; A, acidic motif ; SHD, Sla1-homology domain; SH3, Src homology 3 domain; CTR, C-terminal repeats; EVH1, Ena/VASP homology 1 domain; VCA, verprolin homology/connector/acidic motif.](315fig2){#fig2}

Cargo sorting signals and adaptors {#s6}
----------------------------------

Endocytic adaptors recognize cytoplasmic sorting signals in cargo proteins and couple the cargo to the coat. There are generally two types of sorting signals: short peptide motifs and covalently attached ubiquitin molecules ([@bib315]). Different adaptors recognize different sorting signals on transmembrane proteins at the plasma membrane. Key open questions include uncovering the code that matches each adaptor with each cargo and learning whether particular classes of cargo are targeted by adaptors in response to specific environmental changes.

### Ubiquitin as a sorting signal: {#s7}

Ubiquitin (Ub) is a conserved, 76 amino acid protein that can be covalently linked to substrate proteins via a cascade of three enzymes: E1 (Ub-activating), E2 (Ub-conjugating), and E3 (Ub-ligase) ([@bib384]). Commonly, Ub is linked to a lysine residue in the substrate protein, and since Ub itself has lysines on its surface, it can act as a target for Ub-ligases to produce poly-Ub chains. In mammalian cells, Ub modifications are important for intracellular sorting events at endosomal compartments ([@bib105]). There were hints that Ub might contribute to endocytic regulation in yeast starting in the mid-1990s; high-copy Ub was found to suppress the lethality associated with clathrin deletion ([@bib272]), and some plasma membrane cargoes were found to be ubiquitylated prior to their internalization ([@bib203]; [@bib162]; [@bib168]; [@bib325]). A key role of Ub as a signal for endocytic internalization was shown by the translational fusions of Ub to a mating pheromone receptor ([@bib369]). We now know that Ub-labeled endocytic cargo can either be mono-ubiquitylated (note that more than one lysine can be modified, generating a multi-ubiquitylated protein) or bear K63-linked poly-Ub chains. The major enzyme responsible for covalent attachment of Ub to endocytic transmembrane cargo proteins is the E3 ligase [Rsp5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000927) ([@bib354]). [Rsp5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000927) substrate selection is influenced by protein kinases such as [Npr1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005127) ([@bib195]; [@bib85]; [@bib233]; [@bib247]), raising the question of how the kinase activities are controlled.

### α-Arrestins bridge Rsp5 and cargo substrates: {#s8}

[Rsp5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000927) contains three WW domains that promote binding to \[L/P\]PxY motifs in its substrates ([@bib196]); however, many Rsp5-dependent substrates, including transmembrane proteins, lack \[L/P\]PxY motifs. Recent work has uncovered an important role for the \[L/P\]PxY motif-containing α-arrestin family in bridging [Rsp5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000927) to specific transmembrane cargo destined for covalent Ub modification and internalization. This family consists of 13 known members, many with partially redundant functions; additionally, many cargo proteins are able to functionally interact with multiple α-arrestins ([@bib224]; [@bib276]). The precise mechanisms by which cells regulate binding of transmembrane cargo to α-arrestins are unclear, but may be dictated by physiological or environmental conditions ([@bib276]; [@bib233]; [@bib247]). Another recent finding involves the action of the N-terminal "LID" domain found in permeases, a transmembrane cargo family; this LID domain undergoes a conformational change when the permease is nonfunctional or misfolded, triggering an Rsp5-dependent (but α-arrestin independent) Ub modification ([@bib197]). It will be interesting to learn more about α-arrestin-dependent and -independent routes that govern plasma membrane protein turnover.

### Ub-binding endocytic adaptors: {#s9}

The first ubiquitin interaction motif (UIM) identified found was a conserved α-helical motif in the [Rpn10](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001243)/S5a subunit of the proteasome S19 domain ([@bib170]). The realization that a UIM could predict Ub-binding activity stimulated the study of a number of endocytic proteins with UIMs, in particular the epsin proteins. The two epsin proteins in *S. cerevisiae*, [Ent1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002320) and [Ent2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004196), are members of the middle coat. Initial studies suggested that the epsins might act as endocytic adaptors for binding to covalent Ub modifications on cargo ([@bib6]). More recent work suggests that these and other Ub-binding proteins (*e.g.*, [Ede1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000143) and its UBA domain) may instead utilize their Ub-binding regions for self-regulation, similar to what has been proposed for their mammalian counterparts ([@bib93]). Another Ub-binding adaptor protein is the late coat protein [Sla1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000103), which uses one of its SH3 domains to bind Ub via an unconventional interaction ([@bib355]). Interestingly, [Sla1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000103) and its mammalian homolog CIN85 also bind to Ub E3 ligases, a requirement for the internalization of certain receptors ([@bib362]; [@bib373]).

### Peptide-based sorting motifs and their adaptors: {#s10}

The concept of peptide-based sorting motifs originally emerged from studies of familial hypercholesterolemia, in which it was discovered that the Tyr-x-x-hydrophobic signal in the cytosolic tail of the LDL (low density lipoprotein) receptor directs internalization of LDL particles ([@bib12]). Since then, numerous other peptide-based sorting motifs have been recognized in the tails of many animal cell cargo proteins, mediating selection and sorting at various organelles along the secretory and endocytic pathways.

The only endocytic peptide sorting motif characterized in yeast to date is the NPF(*x*)~1,2~D sorting motif ([@bib364]). NPF tripeptide motifs are hereafter labeled as NPF~motif~, to distinguish them from the NPF acronym used later (see *Mechanisms of Actin Assembly and Turnover***)** in reference to actin nucleation promoting factors (NPFs). Although most NPF~motifs~ are bound by EH domains, typically the NPF(*x*)~1,2~D sorting motif is not ([@bib295]; [@bib172]). Instead, the NPF(*x*)~1,2~D motif binds the adaptor protein [Sla1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000103), via its SH3-like SHD1 ([Sla1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000103) homology domain 1) ([@bib172]; [@bib236]). One possible reason for this distinction may be the influence of other [Sla1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000103) binding partners, such as membrane or cargo (via Ub), but more work is needed to resolve this. Sla1-interacting transmembrane cargo bearing the NPF(*x*)~1,2~D motif (or a variant) include the mating pheromone receptors [Ste2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001868) and [Ste3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001661), the cell-wall stress sensor [Wsc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005534), and the phospholipid flipases [Drs2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000024) and [Dnf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000968) ([@bib172]; [@bib227]; [@bib302]).

In animal cells, the C-terminal extension of the μ-subunit of the heterotetrameric AP complexes (and related domains), known as the μHD domain, has well-known peptide-sorting motif-binding activities ([@bib287]; [@bib187]; [@bib252]). The yeast early coat protein [Syp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000626) contains a μHD domain, suggesting a role for [Syp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000626) as an adaptor ([@bib316]). It is interesting to define the sorting motif recognized by the [Syp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000626)--μHD and to learn whether other yeast adaptors similarly use peptide sorting motifs. In addition, it is important to continue the search for new adaptors.

Initiation of endocytic sites {#s11}
-----------------------------

Endocytic proteins in the early coat are the first to arrive at a nascent endocytic site during the initiation phase ([Figure 1](#fig1){ref-type="fig"}, step 2), and include clathrin, AP-2, [Ede1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000143), [Syp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000626), and [Pal1](http://www.yeastgenome.org/locus/S000002756/overview) ([@bib190]; [@bib39]; [@bib57]; [@bib316]; [@bib58]). There are many questions about the early coat proteins, including what their functions are (both individually and as a group), what triggers their initial recruitment to the membrane, and why the majority of endocytic sites occur at/near sites of polarized growth. Another question is how yeast clathrin is recruited to these sites, since none of the early coat proteins are known to bind clathrin ([Figure 2](#fig2){ref-type="fig"}), with the possible exception of YAP180 (whose arrival time is debated in the literature; see below). Interestingly, among all the stages of endocytosis, the initiation phase is the most variable in length ([@bib274]; [@bib374]; [@bib39]; [@bib58]), raising questions about what leads to this variability and what triggers or checkpoints govern progression to subsequent recruitment of middle coat proteins.

### Early coat proteins: {#s12}

Two of the earliest-arriving coat proteins, [Ede1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000143) and [Syp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000626), directly bind each other ([@bib39]; [@bib316]; [@bib357]). [Ede1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000143) most closely resembles the mammalian endocytic protein Eps15, which is classified as a combination scaffold/ubiquitin adaptor ([@bib119]; [@bib309]). The N-terminal region contains three EH domains (which bind NPF~motifs~), and the C-terminal region includes an ubiquitin-binding UBA domain. The mammalian proteins FCHO1 and FCHO2 are homologs of [Syp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000626) and have been implicated in stabilizing nascent clathrin-coated pit structures ([@bib165]; [@bib75]). Members of this family have a domain layout consisting of an N-terminal F-BAR domain (an anti-parallel homodimerizing membrane-binding domain), a central unstructured region that contains a proline-rich domain, and a C-terminal cargo-binding μHD (see above; [@bib287]; [@bib316]). While the F-BAR domain binds to membranes with a particular curvature ([@bib159]), the unstructured central region contains a high-affinity membrane-binding activity that is sufficient to mediate strong membrane association. This region of [Syp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000626) also directly binds and inhibits the actin polymerization functions of [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) (([@bib39]; [@bib111]); see *Mechanisms of Actin Assembly and Turnover*). Although *[ede1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000143)∆* or *[syp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000626)∆* cells have relatively mild endocytic phenotypes, these defects are consistent with the observed roles in mammalian cells, such as influencing the localization of clathrin and reducing the number and stability of endocytic patches ([@bib190]; [@bib316]; [@bib357]; [@bib58]).

The early coat protein [Pal1](http://www.yeastgenome.org/locus/S000002756/overview) is another member of an [Ede1](http://www.yeastgenome.org/locus/S000000143/overview)-containing complex ([@bib133]; [@bib58]). [Pal1](http://www.yeastgenome.org/locus/S000002756/overview) appears to be specific to fungi and has no characterized domains that hint at its functions, although it does have two copies of the NPF~motif~. The *S. pombe* homolog of Pal1 is implicated in regulating cell polarity ([@bib134]), which is interesting since endocytic sites in *S. cerevisiae* initiate in a polarized manner ([@bib1]). The *S. cerevisiae* genome encodes a paralog of [Pal1](http://www.yeastgenome.org/locus/S000002756/overview), called [Yhr097c](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001139), but it seems unlikely to contribute to endocytosis given its localization to intracellular sites and its relative lack of genetic or physical interactions with other endocytic machinery (*Saccharomyces* Genome Database, <http://www.yeastgenome.org>).

Yeast AP-2 complex is also an early coat component. It is homologous to the mammalian AP-2 complex, except that the yeast complex does not bind clathrin ([@bib420]). As mentioned above, yeast AP-2 has a role in killer toxin internalization. In addition, it was recently shown to be involved in the maintenance of cell-wall integrity by acting as the endocytic cargo adaptor for the cell-wall stress-sensor [Mid2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004324) ([@bib63]). Beyond these roles, little else about the function and regulation of AP-2 in yeast is known. Thus, many questions remain open about its recruitment to the early coat and/or the plasma membrane and how it interacts with other early coat proteins.

### Early coat protein dynamics are variable: {#s13}

While the temporal behaviors of most endocytic protein "modules" ([Figure 1](#fig1){ref-type="fig"}) are invariant in wild-type cells ([@bib190]), the early coat is an exception, ranging in lifetime from 30 to 180 sec ([@bib274]; [@bib374]; [@bib39]; [@bib58]). This variability may reflect a putative checkpoint that monitors the packaging of cargo at an endocytic site ([@bib229]; [@bib58]) and restricts progress until cargo is suitably concentrated or organized. Recently, it was found that the regions of the cell with the highest concentrations of newly delivered exocytic proteins (some of which are undoubtedly endocytic cargo) colocalize with the most rapidly maturing early coat patches ([@bib216]), consistent with the checkpoint model. However, the major cargo-binding components of the endocytic patch are not recruited until later steps (see below). Whatever the precise cause of temporal variability, it is clear that some trigger causes a transition within the early coat proteins and/or the underlying membrane that allows the next wave of proteins to join the endocytic site.

Early coat proteins appear to have differing roles in regulating later-arriving endocytic proteins. Both *[ede1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000143)∆* and *[chc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003174)∆* cells display shorter residence times of the late coat protein [Sla1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000103) (see below) and a reduced number of Sla1-containing patches at steady state ([@bib190]; [@bib274]). Intriguingly, these effects on late coat behavior are apparently specific to *[chc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003174)* and *[ede1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000143)* mutants and are not seen in *[pal1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002756)*, *[syp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000626)*, or AP-2 mutants ([@bib57]; [@bib58]). Further analysis may shed light on how clathrin and [Ede1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000143) influence later-arriving endocytic proteins and/or other early coat components and may uncover a link to the putative cargo checkpoint.

Another feature of the early coat is the differential spatial behavior of its constituents. Clathrin, AP-2, and [Pal1](http://www.yeastgenome.org/locus/S000002756/overview) all move inward with the coat during the mobile phase, while [Ede1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000143) and [Syp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000626) remain at the plasma membrane ([@bib357]). This is consistent with the activity of [Syp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000626), which inhibits the polymerization of actin (see below); perhaps [Ede1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000143) also negatively regulates an activity required for the later stages and must disperse to promote the mobile phase.

Maturation of endocytic sites {#s14}
-----------------------------

"Maturation" refers to the events that occur between the end of the variable early coat initiation phase and the beginning of the mobile invagination/scission phase and typically lasts for about 30 sec. During this interval, the coat transitions to a more stereotypical behavior and prepares for assembly of the actin network. Initially, characterization of the temporal and spatial dynamics of endocytic proteins had not included the early coat proteins and was focused on the immobile coat proteins that became mobile when F-actin appeared ([@bib189]). However, subsequent studies with higher-resolution time-lapse analyses of many more proteins revealed a need to further classify endocytic components into middle coat *vs.* late coat proteins ([@bib72]). This more refined classification should facilitate the identification of which proteins influence the transitions from initiation to maturation to scission. The middle coat proteins represent major links to clathrin and cargo ([Figure 2](#fig2){ref-type="fig"}), while the late coat proteins are regulators of actin dynamics (see *Mechanisms of Actin Assembly and Turnover*). As discussed in more detail below, there is some uncertainty as to whether the membrane curvature/invagination stage precedes or coincides with the appearance of actin.

### Middle coat proteins: {#s15}

The first middle coat proteins to join the early coat patch are likely to regulate the transition between the end of the early coat-based initiation phase and the next step in endocytosis. Several observations point to [Sla2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005187) playing a role in this transition. First, [Sla2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005187) physically interacts with three early coat proteins ([Ede1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000143), [Syp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000626), and Pal1) ([@bib133]). Second, [Sla2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005187) arrives ∼6 sec before the late coat protein [Sla1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000103) ([@bib274]). Third, an interaction between [Sla2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005187) and clathrin light chain in turn affects the timing of [Sla1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000103) recruitment ([@bib274]; [@bib40]), suggesting that the early coat together with [Sla2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005187) influences later stages of endocytosis.

[Sla2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005187) is the yeast homolog of HIP1R (Huntingtin interacting protein-1 related). [Sla2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005187) and HIP1R are both homodimeric proteins and have N-terminal membrane-binding ANTH (AP180 N-terminal homology) domains, central coiled-coil regions that bind clathrin light chain, and C-terminal F-actin-binding THATCH (talin-HIP1/R/[Sla2p](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005187) actin-tethering C-terminal homology) domains ([@bib408]; [@bib418]; [@bib166]). In both yeast and mammals, [Sla2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005187)/HIP1R has been implicated in linking the endocytic coat to F-actin and may direct actin polymerization and force generation to facilitate membrane invagination. In the absence of [Sla2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005187)/HIP1R, uncontrolled polymerization of F-actin occurs without associated vesicle formation, resulting in actin comet tail structures ([@bib189]). This is now called an uncoupling phenotype, where actin polymerization appears to be unlinked from membrane invagination ([@bib44]; [@bib345]). However, the comet tails in *[sla2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005187)∆* cells are likely associated with at least small membrane invaginations, as suggested by immuno-EM studies and by the observation that FM4-64 accumulates in plasma membrane-associated punctae in these cells ([@bib356]; [@bib180]). Intriguingly, clathrin mutants also exhibit actin comet tails; they are distinct in shape and size from those found in *[sla2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005187)∆* cells, but this still suggests that clathrin may also be involved in the coupling of the coat to actin, perhaps via the [Sla2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005187)/[Clc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003399) interaction described above ([@bib274]).

The yeast epsins [Ent1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002320) and [Ent2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004196) have been defined as middle coat proteins based on both the timing of their arrival at patches and their functional links to [Sla2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005187) ([@bib374]; [@bib345]). [Ent1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002320) and [Ent2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004196) are an essential pair of clathrin adaptor proteins whose epsin N-terminal homology (ENTH) domains bind PtdIns(4,5)P~2~ and play a crucial role in signaling to the polarity-regulating GTPase [Cdc42](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004219) ([@bib407]; [@bib7]). [Ent1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002320) and [Ent2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004196) each contain two ubiquitin-interaction motifs (UIMs) adjacent to their ENTH domains; further, their intrinsically disordered C-terminal domains harbor an NPF~motif~ and a variant clathrin box motif that binds the terminal domain of clathrin ([@bib407]; [@bib192]; [@bib404]). The epsin C-terminal domain also binds actin ([@bib345]).

Recent evidence has implicated [Ent1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002320) and [Ent2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004196) in the transmission of force from actin polymerization to the plasma membrane, in complex with [Sla2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005187). First, the [Sla2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005187) THATCH domain was found to be required for endocytosis in *[ent1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002320)[ent2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004196)* mutant cells ([@bib19]). Second, the lipid binding ANTH domain of [Sla2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005187) heterodimerizes with the lipid-binding ENTH domain of [Ent1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002320) or [Ent2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004196) and cooperatively binds the plasma membrane ([@bib345]).

Two additional coat proteins are [Yap1801](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001204) and [Yap1802](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003473), yeast homologs of the clathrin assembly lymphoid myeloid leukemia protein (CALM), a ubiquitously expressed clathrin adaptor ([@bib95]; [@bib72]). There is some disagreement in the literature about the precise temporal recruitment of the Yap180 proteins, as different groups observed them in either the early or middle coat, possibly influenced by the different positions of the GFP tags ([@bib58]; [@bib72]). [Yap1801](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001204)/2 in yeast and CALM homologs in other organisms have conserved functions in endocytosis and in recycling of the v-SNARE [Snc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000028)/VAMP ([@bib238]). Like [Sla2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005187), the [Yap1801](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001204)/2 proteins have N-terminal lipid-binding ANTH domains, and like the epsins they have intrinsically disordered C termini; [Yap1801](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001204)/2 and the epsins also have common binding partners (clathrin and EH domain scaffolds) ([@bib405]). Further, yeast cells lacking all four of these related proteins ([Ent1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002320), [Ent2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004196), [Yap1801](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001204), and [Yap1802](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003473)) exhibit temperature-sensitive growth and endocytic defects ([@bib237]).

### Late coat proteins: {#s16}

Another cohort of endocytic proteins defines the late coat ([@bib190]; [@bib72]). Many late coat proteins associate with each other, with early and middle coat proteins, and with actin regulatory factors recruited in the final invagination/scission stage ([Figure 2](#fig2){ref-type="fig"}). As described below, [Sla1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000103) is currently thought to shepherd the transition from the middle to late coat stages.

[Sla1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000103) is a critical late coat protein that was among the first clear links discovered between the endocytic and actin machineries ([@bib396]). [Sla1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000103) has numerous binding partners and regulatory interactions and the capacity to both positively and negatively regulate endocytosis. Its domain layout consists of three SH3 domains, two distinct conserved [Sla1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000103) homology domains (SHD1 and SHD2), a clathrin-binding motif, and a C-terminal region that is heavily phosphorylated by actin-regulating kinase (ARK) family kinases (see *Vesicle Scission and Uncoating*). [Sla1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000103) is subject to autoinhibition, as its SHD2 domain binds to and inhibits the clathrin-binding motif ([@bib91]). [Sla1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000103) forms a complex with two EH domain-containing late coat proteins, [Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445) and [End3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005028) ([@bib365]; [@bib366]). Recently, the specific domains in [Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445) and [End3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005028) mediating their interaction were identified, and it was shown that this interaction is required for [Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445) phosphoregulation ([@bib409]). This [Sla1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000103)--[Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445)--[End3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005028) trio may be the yeast functional counterpart to mammalian endocytic scaffold/signaling protein Intersectin, which has EH and SH3 domains in a single polypeptide ([@bib416]).

Studies have shown that once [Sla1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000103) is recruited, an endocytic patch is highly likely to assemble F-actin and undergo internalization ([@bib274]). Thus, the mechanism of [Sla1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000103) recruitment appears to be linked to the mechanism that deems a patch ready to transition from the immobile to the mobile phase. What underlies this key transition step remains unknown, but is likely affected by phosphoregulation (see below). It is possible that [Sla1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000103) monitors patch maturation by "sensing" the status or concentration of clathrin. As noted above, [Sla1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000103) residence in patches is reduced in *[chc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003174)∆* cells ([@bib190]), and cells expressing a *[sla1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000103)* mutant that cannot bind clathrin are defective for internalization of the Sla1-dependent cargo protein [Wsc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005534) and have significantly longer lived patches ([@bib91]). However, further work is needed to fully understand this mechanism.

[Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445) is another critically important late coat protein; surprisingly, it is the only component of the endocytic coat that is essential for viability (in addition to the clathrin heavy chain in certain strain backgrounds mentioned above) ([@bib329]; [@bib406]). Whether the essential function of [Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445) is tied to its role in endocytosis has not yet been determined, but given its subcellular localization to cortical patches, the phenotypes of *[pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445)* mutant cells, and numerous physical and genetic interactions ([@bib253]), it is clear that it plays a central, and perhaps essential, role in endocytosis.

[Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445) was originally misidentified as a poly(A)-binding protein-dependent poly(A) nuclease (hence its name, [Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445)), but [Pan2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003062) was later shown to harbor this nuclease activity ([@bib329]; [@bib38]). After realizing that [Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445) in fact is an endocytic protein, the clathrin-binding adaptor proteins [Yap1801](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001204)/2 and [Ent1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002320)/2 were identified as binding partners of [Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445)'s conserved EH domains ([@bib405]; [@bib407]). The Cai lab independently connected [Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445) to endocytosis through suppressor screens, which also identified the late coat proteins [Sla1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000103) and [End3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005028) and the regulatory protein kinase [Prk1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001357) (a member of the ARK kinase family) ([@bib365], [@bib366]). The Drubin lab later showed that [Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445) binds the Arp2/3 complex and can stimulate its actin nucleation activity, thereby linking [Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445) to actin regulation ([@bib99]). Further, [Sla2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005187) interactions with [Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445) were shown to inhibit its effects on Arp2/3 complex, providing a potentially important regulatory mechanism ([@bib376]). [Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445) also binds to the type I myosins [Myo3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001612)/5 and facilitates their ability to stimulate Arp2/3 complex ([@bib23]). These many binding partners and activities raise a key question about [Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445), which extends more generally to other coat proteins, which is how do these proteins interact with their binding partners in the correct temporal sequence when the partners are often recruited at distinct stages of the endocytic process?

A final late coat protein, [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707), arrives coincidentally with [Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445). Since [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) is one of the most potent activators of Arp2/3 complex-mediated actin polymerization, it is discussed below (*Mechanisms of Actin Assembly and Turnover*).

Mechanisms of Actin Assembly and Turnover {#s17}
=========================================

In this section we focus on events that occur at endocytic sites after the recruitment of the early, middle, and late coats (above) and that produce a short and critically required burst of actin assembly that drives vesicle scission and internalization ([@bib189], [@bib190]) ([Figure 1](#fig1){ref-type="fig"} and [Figure 3](#fig3){ref-type="fig"}). Although this phase of endocytosis lasts only 15--20 sec, it is the major force-generating step in the endocytic process and results in all of the extreme membrane remodeling events that accompany endocytic internalization. Patches also reach their peak of molecular complexity at this phase, since most earlier components remain present and \>30 new proteins arrive ([Table 2](#t2){ref-type="table"}).

![Endocytic patch dynamics and ultrastructure. (A and B) Longitudinal EM sections through cortical actin patches in fixed yeast cells visualized with anti-actin and anti-HA-Sla2 immunogold labeling respectively ([@bib262]; [@bib179]). (C) Scheme of F-actin at a cortical actin patch circa 1994, adapted from Mulholland *et al.* 1994. (D--F) Localization of Sla2--GFP and Abp1--CFP by live cell fluorescence imaging ([@bib189]). (D) A single frame from a time-lapse series; Sla2-GFP in green, Abp1--CFP in red. (E) Tracking of consecutive positions of the indicated proteins from consecutive frames; dashed line, plasma membrane. Green dot, starting position when the patch appears; red dot, final position when the patch dissipates. (F) Individual frames from a time-lapse series showing distinct arrival/departure of Sla2 *vs.* Abp1 at an individual endocytic patch; frames acquired every 2.8 sec. (G) Electron tomograms of plasma membrane structures at various stages of endocytosis ([@bib210]). Dashed circles are zones of 50 and 80% prediction accuracy for the correlated position of fluorescent Abp1--mCherry signal, independently acquired. Dark electron densities, corresponding to ribosomes, are excluded from the region around the membrane invagination, presumably due to the dense F-actin network. (H) Schematic of electron tomograms, presenting the shape and positions of endocytic structures and the ribosome "exclusion zone" (interpreted as the actin-rich zone) at selected stages of endocytosis. Shaded lines overlay the data from individual EM tomograms; solid outline is the average shape at each stage. Adapted from [@bib210].](315fig3){#fig3}

Over the past 17 years, there have been major advances in defining the activities, mechanisms, and structures of actin-associated components, as well as their physiological interacting partners, dynamics, and cellular roles. Moreover, from quantitative live-cell imaging studies we know the timing of arrival of most actin-associated protein components, their molar ratios in cells, and even the number of molecules per endocytic site for many of these proteins. Finally, EM studies have defined the shape and dimensions of endocytic invaginations and surrounding actin networks ([Figure 3, G and H](#fig3){ref-type="fig"}). With this information, it has been possible to begin answering central mechanistic questions about this actin-based phase of endocytosis, including: How is the timing of actin assembly regulated at endocytic sites, and what mechanisms initiate actin polymerization? How are the size, shape, and geometry of the actin networks determined? How is a particular set of actin-associated proteins recruited to the actin filaments in patches, while a different set is recruited to the other major actin structures in yeast: actin cables and the cytokinetic ring ([Figure 4](#fig4){ref-type="fig"})? Finally, how does the actin patch network provide directional force to drive vesicle invagination and scission?

![A comparison of the four stages in formation and turnover of actin patches *vs.* cables. Scheme of the ultrastructure of a cortical actin patch (top) and cable (middle); legend defining the icons (bottom). Both structures are initiated by the nucleation of filaments from ATP-bound G-actin (left). Then, F-actin is stabilized/crosslinked and subsequently severed and disassembled. The released ADP-actin monomers undergo nucleotide exchange to replenish the pool of polymerization-competent ATP-G-actin (right side). Some icons represent groups of proteins with related activities (*e.g.*, Arp2/3 complex NPFs, disassembly cofactors of cofilin). This cycle takes ∼5 sec to complete in each type of actin structure; due to distinct nucleation rates, it occurs within the \<300 nm ribosome exclusion zone in an actin patch *vs.* \>5000 nm along the length of an actin cable. See *Mechanisms of Actin Assembly and Turnover* for details.](315fig4){#fig4}

The working model we arrive at (described below) helps to explain how \>30 different actin regulatory proteins arrive at patches within 5--7 sec of each other and work in concert to initiate the rapid formation of an actin network, stimulate its dynamic turnover and remodeling, and ultimately dismantle the network and recycle its components ([Figure 4](#fig4){ref-type="fig"}). In many ways, this process can be compared to *Listeria* actin-based motility, which requires both focused nucleation at the bacterial surface and rapid turnover of the network ([@bib371]). Similarly, latex beads coated with actin nucleators found at yeast endocytic sites (see below), when mixed with yeast-cell extracts, reconstitutes *in vitro* bead motility ([@bib250]). Force generation by actin networks in both motility and endocytosis can be explained by the Brownian ratchet and elastic Brownian ratchet models, in which actin polymerization produces work by polymerizing to fill small gaps between the actin network and membrane created by Brownian motion ([@bib191]). In these models, actin polymerization must be focused at the membrane, consistent with nucleation and elongation machinery being typically found at these sites. Capping proteins are additionally required to focus polymerization at new nucleation sites and to maintain network architecture, and filament branching and crosslinking factors are necessary to hold a network together to enable force production. The precise organization and orientation of actin filaments in yeast actin patches is still being worked out, but most evidence suggests that the barbed ends face the cell cortex, at least at early stages of membrane invagination (details below).

In the subsections below, we describe in detail the molecular machinery and mechanisms underlying each major step in actin regulation that occurs during yeast endocytosis: (A) actin nucleation, (B) actin-filament capping, crosslinking, and stabilization, and (C) actin-filament disassembly and turnover ([Figure 4](#fig4){ref-type="fig"}). Genetic analysis has shown that each step is crucial for endocytosis, presumably because the rapid assembly and turnover of the actin networks provides: (i) directional force to drive plasma membrane tubulation and vesiculation and (ii) plasticity necessary for the actin network surrounding the membrane invagination to be dynamically resculpted as the geometry of the membrane changes ([Figure 1, G and H](#fig1){ref-type="fig"}).

Actin nucleation {#s18}
----------------

Actin is a ubiquitous, abundant, and conserved 42-kDa protein that binds ATP and exists in either a globular (monomeric) form called G-actin or a filamentous (polymeric) form called F-actin. Actin filaments are polarized, helical, two-stranded polymers with a fast-growing "barbed" end and a slow-growing "pointed" end, named for their appearances in electron micrographs after decoration with myosin S1 fragment. The critical concentration for assembly of yeast and animal actins is ∼0.15 µM, yet their cytosols maintain micromolar levels of actin monomers; thus cellular conditions strongly favor actin assembly over disassembly. What limits the growth of actin filaments in yeast and animal cells is the production and/or availability of "free" (uncapped) barbed ends of filaments onto which actin subunits can be rapidly added. Because free ends are limiting, a reservoir of ATP-actin monomers builds up in cells, poised for growth once free ends become available. Profilin is a small, abundant cellular protein that preferentially binds ATP-actin monomers and blocks their addition onto pointed ends but freely allows addition onto barbed ends ([@bib372]; [@bib306]; [@bib154]; [@bib155]; [@bib100]). Thus, actin polymerization *in vivo* is restricted to barbed ends, and the generation of free barbed ends is a key regulatory step in actin network formation.

In principle, there are three distinct mechanisms by which free barbed ends can be generated. Existing capped filaments can be uncapped, existing filaments can be severed to produce new ends, and new filaments can be formed *de novo* from monomers. Although there is some evidence for uncapping and severing contributing to the growth of actin networks in animal cells ([@bib77]), rich evidence demonstrates that the primary mechanism for stimulating actin network growth is regulated nucleation ([@bib305]; [@bib307]).

While actin monomers are rapidly added to existing filaments barbed ends (11.6 subunits sec^-1^ µM^-1^; [@bib304]), they do not readily self-nucleate to form new filaments in the absence of other factors. This is because polymerization intermediates, actin dimers and trimers, are extremely short lived and rapidly dissociate back into monomers ([@bib336]). In addition, profilin further suppresses nucleation by blocking longitudinal (long-pitch) actin--actin contacts ([@bib334]). In yeast and other organisms, these kinetic barriers to nucleation are overcome by activation of specialized actin regulators, called nucleators, which structurally mimic a filament end, stabilize polymerization intermediates, or recruit and organize monomers into filament seeds ([@bib71]; [@bib54]).

Two distinct sets of actin assembly-promoting machinery have been identified in yeast, the Arp2/3 complex and formins ([Figure 4](#fig4){ref-type="fig"}). Endocytic actin patches are nucleated by the combined activities of Arp2/3 complex and its cofactors, called nucleation-promoting factors (NPFs, unrelated to the NPF~motif~ discussed in *Cargo Selection and Coat Formation*). Actin cables and cytokinetic rings are nucleated instead by formins ([Bni1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005215) and [Bnr1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001421)) working in combination with a different set of cofactors, which includes [Bud6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004311), profilin, and tropomyosin. Yeast actin structures (patches, cables, and rings) each have a distinct shape, function, architecture, and molecular composition ([@bib259]). How these differences are programmed is not yet understood, but may stem in part from which nucleator is used to initiate the actin network ([@bib249]). Further, the relative amount of actin distributed between different types of actin networks (*e.g.*, patches and cables) is controlled by homeostatic mechanisms, in which the nucleators in these different structures compete for a limiting pool of G-actin in the cytosol ([@bib130]; [@bib50]). This balance can also be shifted by any of the complex sets of stimulatory and inhibitory interactions that control the activity states of the nucleator systems (see below).

### The Arp2/3 complex: {#s19}

The Arp2/3 complex (∼200 kDa), which was first isolated from *Acanthamoeba* cell extracts ([@bib234]), consists of seven subunits and is conserved across distant species of animals, plants, and fungi ([@bib401], [@bib402]). It was also the first *bona fide* actin nucleator identified ([@bib401]; [@bib264]) and remains the only one that nucleates branched filaments, polymerizing new "daughter" filaments from the sides of existing "mother" filaments at a 70° angle ([@bib264]). Thus, the Arp2/3 complex forms branched networks, such as those found at the leading edge of motile cells ([@bib361]) and at endocytic sites in yeast and mammalian cells ([@bib422]; [@bib323]; [@bib76]). Given its two actin-related protein (Arp) subunits ([Figure 5A](#fig5){ref-type="fig"}), there was early speculation that the complex might directly nucleate actin polymerization ([@bib263]), and shortly thereafter seminal work from the Mitchison and Pollard labs demonstrated that this is the case ([@bib401], [@bib402]; [@bib235]). Importantly though, the Arp2/3 complex alone has minimal activity, and strong nucleation requires binding of an NPF. Four NPFs have been identified in yeast (see below), with the Wiskott--Aldrich syndrome protein (WASP), called [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) in yeast, being the best characterized. [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707)/WASP contains a C-terminal VCA (or WCA) region (detailed below), which is sufficient to bind Arp2/3 complex and actin monomers and stimulate actin nucleation *in vitro*.

![Mechanism of Arp2/3 complex-mediated actin branch formation stimulated by WASP/Las17. (A) Crystal structure of bovine Arp2/3 complex ([@bib319]), in the conformation corresponding to open labeled with the arrow in B. Individual subunits are labeled and color-coded. (B) Distinct conformations of purified *S. cerevisiae* Arp2/3 complex, visualized by negative-stain EM and single particle averaging ([@bib322]). The open conformation corresponds to the inactive state, and the closed conformation is primed for nucleation. (C) Single-molecule time-lapse TIRFM imaging of Arp2/3-mediated branch formation (adapted from [@bib349]). Actin daughter filament (blue) nucleated by SNAP-tagged Arp2/3 complex (red) stimulated by dimeric Cy3-labeled WASP (VCA domain, green). A selection of frames is shown from time points at −20, 0, 5, 40, and 100 sec, with 0 sec defined when VCA releases from Arp2/3. (D) Scheme describing the reaction steps leading to branched actin network formation near cellular membranes. WASP/Las17 binding to Arp2/3 closes the complex to bind the side of an existing F-actin mother filament. Elongation of the mother filament against the plasma membrane causes release of WASP/Las17 from Arp2/3 and nucleation/elongation of the daughter filament branch (adapted from [@bib349]).](315fig5){#fig5}

A critical advance in our understanding of the Arp2/3 complex mechanism came with publication of its crystal structure, solved for bovine Arp2/3 ([@bib319]) ([Figure 5A](#fig5){ref-type="fig"}). This provided a wealth of information to guide subsequent genetic and biochemical dissections of individual subunits defining Arp2/3 function, mechanism, and regulation in yeast ([@bib28]; [@bib83]; [@bib240]; [@bib84]; [@bib21]; [@bib141]). The structure of the complex also revealed that the [Arp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002187) and [Arp3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003826) subunits were well separated from each other, suggesting that an activation step might be required to bring [Arp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002187) and [Arp3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003826) into register for nucleation. This hypothesis was confirmed both by EM and FRET studies, which showed that WASP triggers a conformational change in yeast or human Arp2/3 complex, shifting it from an "open" (inactive) state to a "closed" (primed for nucleation) state ([Figure 5B](#fig5){ref-type="fig"}) ([@bib140]; [@bib322]). Further insights came from electron micrographs and 3D reconstructions of yeast Arp2/3 complex at filament branch sites, which revealed that additional conformational rearrangements in the complex occur upon mother filament binding ([@bib326]). Moreover, addition of preformed filaments was shown to catalyze nucleation by VCA and bovine Arp2/3 complex ([@bib169]). These results suggest that robust nucleation by Arp2/3 complex requires interactions with both an NPF and a mother filament.

Studies comparing yeast and mammalian Arp2/3 complex activities have revealed some differences that may be relevant, including partial nucleation activity by yeast Arp2/3 complex in the absence of NPFs, *i.e.*, weak activation by F-actin alone ([@bib413]; [@bib144]; [@bib322]; [@bib403]). However, genetic studies show that NPFs are essential for cell viability and endocytosis ([@bib106]; [@bib217]); thus, nucleation by Arp2/3 without NPFs is not sufficient *in vivo*. Still, this low-level NPF-independent nucleation activity of yeast Arp2/3 complex could be important during endocytosis; *e.g.*, NPFs may control network initiation as well as ongoing polymerization at the membrane, while NPF-independent nucleation may contribute to reinforcing the network away from the membrane.

One of the ultimate goals in studying Arp2/3 complex mechanism is to define the precise order and timing of each step in the nucleation pathway. This is extremely challenging however, because it involves a complex set of interactions involving Arp2/3 complex, NPFs, F-actin, and G-actin. Some of the individual steps in this pathway were elegantly defined by measuring the rate constants of specific interactions involved, allowing investigators to build models of the pathway ([@bib29]). However, key steps in such models required speculation where direct measurements were not available, which left gaps in our understanding. More recently, multi-wavelength single-molecule analysis of fluorescently labeled actin, yeast Arp2/3 complex, and dimerized mammalian WASP--VCA (di-VCA) molecules has allowed direct visualization of the events in real time, making it possible to quantitatively define each step in the pathway ([Figure 5C](#fig5){ref-type="fig"}) ([@bib348],[@bib349]). These studies demonstrated that di-VCA first binds Arp2/3 complex in solution and then diVCA-bound Arp2/3 complex associates with the side of a mother filament, and finally a daughter filament begins to polymerize, but only after di-VCA dissociates from Arp2/3 complex ([Figure 5D](#fig5){ref-type="fig"}).

Importantly, these studies identified several highly inefficient steps in the nucleation pathway, leaving generous room for positive regulation by additional cellular factors. For example, *in vitro* the great majority of complexes that bind the mother filament rapidly dissociate without ever nucleating a daughter filament, so factors that stabilize Arp2/3 complex on mother filament sides could dramatically enhance nucleation. Single-molecule studies now offer a powerful strategy by which to define the precise spatial and temporal effects of each NPF, alone and together, on nucleation and branching ([Figure 5C](#fig5){ref-type="fig"}).

### Nucleation-promoting factors: {#s20}

NPFs directly associate with Arp2/3 complex and actin and serve as cofactors in stimulating nucleation. As mentioned above, there are four known NPFs in yeast: (1) [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707)/WASP, (2) myosin I ([Myo3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001612) or [Myo5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004715)) in a complex with [Vrp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004329)/WIP, (3) [Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445)/Intersectin, and (4) [Abp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000684) ([@bib413]; [@bib106]; [@bib217]; [@bib99]; [@bib144]) ([Figure 6](#fig6){ref-type="fig"}). Each of these NPFs localizes to actin patches, binds to actin and to Arp2/3 complex, stimulates Arp2/3 nucleation activity to some degree *in vitro*, and exhibits genetic interactions with Arp2/3 complex and/or other NPFs. [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707)/WASP and myosin I (with [Vrp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004329)) are categorized as class I NPFs because they bind actin monomers and have strong NPF effects ([@bib359]). [Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445) and [Abp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000684) are categorized as class II NPFs because they bind to F-actin and have comparably weak NPF effects ([Figure 6C](#fig6){ref-type="fig"}). Consistent with this classification, Arp2/3-inactivating mutations in [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) combined with mutations in either myosin I or [Vrp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004329) are synthetic lethal, demonstrating that class I NPF function is essential ([@bib106]; [@bib217]). The roles of [Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445) and [Abp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000684) in regulating Arp2/3 complex during endocytosis are less well understood (see below).

![Arp2/3 complex nucleation-promoting factors (NPFs). The figure depicts three proposed stages of NPF activity. (A) Inhibited NPFs. In earlier stages of patch development well before the arrival of Arp2/3 complex, the NPFs Las17/WASP and Pan1/Intersectin are maintained at patches in an inactive state by direct binding partners and are unable to recruit Arp2/3 complex. (B) Network priming. After subsequent deactivation of their inhibitors, Las17/WASP and Pan1/Intersectin are released to recruit and activate Arp2/3 complex. However, network nucleation also requires priming by one of two proposed mechanisms: (i) the capture or *de novo* assembly of an initial mother filament, which may depend on the Arp2/3-independent activities of Las17, Pan1, and/or Ysc84/Lsb4, or (ii) the stimulation of unbranched actin nucleation by Arp2/3 complex, as Nolen and colleagues have recently demonstrated can be induced by the *S. pombe* homolog of Ldb17/DIP/WISH ([@bib393]). (C) Active nucleation. After the priming stage, the Arp2/3 complex and its NPFs rapidly assemble a densely branched actin-filament network that promotes membrane remodeling. Class I NPFs bind G-actin: Las17/WASP, Vrp1/WIP, and myosin I. Class II NPFs bind F-actin: Pan1/Intersectin and Abp1. Some of the proteins are shown in complexes with their known binding partners. Additional interactions are indicated by dotted lines. Arrows represent stimulatory effects. Illustrations are based on available structural and sequence data. Abbreviations: THATCH, talin-HIP1/R/Sla2p actin-tethering C-terminal homology domain; ANTH, AP180 N-terminal homology domain; F-BAR, FER/Cip4 homology-Bin/Amphiphysin/Rvs domain; µHD, µ homology domain; EH, Eps15 homology domain; LRD, leucine-rich domain; CC, coiled coil; V, verprolin homology motif; C, connector motif; A, acidic motif; SH3, Src homology 3 domain; SHD, Sla1 homology domain; CTR, C-terminal repeats; ADF-H, actin depolymerizing factor homology domain; TH, tail homology domain; WBD, WASP-binding domain; EVH1, Ena/Vasp homology 1 domain; PP, polyproline region.](315fig6){#fig6}

#### Las17/WASP: {#s21}

[Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) (also known as [Bee1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707)) is the yeast homolog of WASP and was first identified as a factor essential for reconstituted actin patch assembly in a permeabilized cell assay ([@bib221]) and then as a multicopy suppressor of *[vrp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004329)* mutants ([@bib271]). [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) contains an N-terminal WASP-homology 1 (WH1)/EVH1 domain that binds to [Vrp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004329)/WIP, followed by a central proline-rich region that binds to a number of SH3 domain-containing proteins (*e.g.*, [Sla1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000103), [Bbc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003557), [Bzz1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001156), [Myo3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001612), [Myo5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004715), [Lsb1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003368), [Lsb2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006358), [Ysc84](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001058), [Sho1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000920), and [Rvs167](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002796)), and finally a C-terminal VCA region ([Figure 6](#fig6){ref-type="fig"}). The ∼10-kDa VCA region consists of a WASP-homology 2 (WH2 or V) domain that binds G-actin, a short "connecting" (C) domain that binds Arp2/3 complex, and an "acidic" (A) domain that binds Arp2/3 complex. Biochemical analyses of yeast and animal WASP homologs have demonstrated two critical mechanistic roles for VCA during nucleation: (i) it induces conformational changes in Arp2/3 complex that promote nucleation, and (ii) it delivers the first actin monomer of the daughter filament via its WH2 (or V) domain ([@bib169]; [@bib324]; [@bib321]) ([Figure 5D](#fig5){ref-type="fig"}). Early models of nucleation proposed binding of a single VCA to a single site on Arp2/3 complex. However, it was later shown that dimerization of human VCA elevates NPF effects substantially and increases VCA affinity for Arp2/3 complex by \>100-fold compared to monomeric VCA ([@bib291]). More recently, it was found that there are two separate VCA-binding sites on bovine Arp2/3 complex ([@bib292]; [@bib370]). Together, these studies suggest that maximal nucleation is achieved by Arp2/3 complex binding two VCAs simultaneously. Another implication of these findings is that the activity of WASP, and possibly other NPFs, can be enhanced by ligand-induced dimerization, and indeed, specific binding partners of [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) (*e.g.*, [Bzz1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001156), which has a dimeric F-BAR domain, [Figure 6C](#fig6){ref-type="fig"}) may function in this capacity.

While the VCA region is critical for yeast [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) NPF effects, even dimerized it has substantially weaker NPF effects compared to full-length [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) ([@bib321]). These observations suggest that other domains in [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) outside of VCA contribute to its robust NPF activity. One recent study identified sequences in the proline-rich (PR) region of [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707), adjacent to the VCA, that bind actin and contribute to NPF activity ([@bib380]). However, the NPF activity of this PR-VCA fragment was still much weaker than that of full-length [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707), suggesting that there is still much to learn about [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) activity. Importantly, this study also reported that some Las17-stimulated actin nucleation was Arp2/3 independent; such activity could contribute to filament initiation at the patch (see below). Purified [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) is also constitutively active rather than autoinhibited like mammalian N-WASP ([@bib321]). So, in this regard [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) is more similar to mammalian SCAR/WAVE proteins, other members of the larger WASP/SCAR/WAVE family ([@bib399]). WAVE proteins are inhibited *in trans* by a large multisubunit WAVE-regulatory complex (WRC) ([@bib101]; [@bib132]; [@bib70]). Although homologs of WRC genes are not found in yeast, a distinct set of Las17-binding partners appears to mediate *trans*-inhibition (see below). Therefore, while the domain layout of [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) resembles WASP, its regulation more closely resembles SCAR/WAVE.

#### Myosin I (Myo3 and Myo5): {#s22}

Type I myosins are considered unconventional within the myosin superfamily because they are single headed, nonprocessive, and lipid associated. There are two yeast homologs of myosin I, called [Myo3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001612) and [Myo5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004715). Each has a motor domain, lipid and F-actin binding domains, an SH3 domain, and an Arp2/3-interacting acidic (A) domain ([Figure 6C](#fig6){ref-type="fig"}). Myosin I NPF activities require both the A domains and interactions of their SH3 domains with [Vrp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004329)/WIP, which in turn binds G-actin ([@bib339]; [@bib359]). Thus, the combination of myosin I and [Vrp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004329) provides a functional equivalent to VCA and delivers actin monomers to Arp2/3 complex. Single deletions of *[MYO3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001612)* or *[MYO5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004715)* cause relatively minor defects *in vivo*, but double mutants show pronounced defects in endocytosis and actin organization ([@bib135]). Both the motor and NPF activities of myosin I are required for its endocytic functions ([@bib359]).

#### Pan1: {#s23}

In addition to its roles as a scaffold protein in organizing other components of the endocytic machinery (see *Cargo Selection and Coat Formation*; [Figure 2](#fig2){ref-type="fig"}), [Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445) contains an Arp2/3-interacting A domain and an unconventional WH2 (V) domain that binds F-actin rather than G-actin ([Figure 6](#fig6){ref-type="fig"}). [Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445) has weak NPF effects on Arp2/3 complex compared to those of [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) or myosin I and [Vrp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004329). The NPF activities of [Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445) depend on its WH2 and A domains ([@bib99]; [@bib376]). [Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445) is categorized as a class II NPF ([@bib399]), but its functions in regulating Arp2/3 complex are still not well understood.

#### Abp1: {#s24}

[Abp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000684) (actin binding protein 1) was first isolated from yeast-cell extracts on an F-actin affinity column ([@bib96]) and later found to be conserved in mammals ([@bib103]; [@bib214]; [@bib198]). It has an N-terminal actin depolymerization factor (ADF)/cofilin-homology (ADFH) domain through which it binds F-actin but not G-actin and two acidic (A) domains that bind Arp2/3 complex ([@bib198]; [@bib144]) ([Figure 6C](#fig6){ref-type="fig"}). The C-terminal half of [Abp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000684) contains a proline-rich region that binds the SH3 domain of [Rvs167](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002796) ([@bib117]) and an SH3 domain that binds [Srv2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005082), [Scp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005894), and the kinases [Ark1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004965) and [Prk1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001357) ([@bib115]; [@bib223]; [@bib109]; [@bib158]); the functions of these proteins are described below. Like [Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445), the NPF effects of [Abp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000684) are weak compared to those of class I NPFs ([@bib359]). Further, because [Abp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000684) binds to F-actin, it is categorized as a class II NPF. Although *[abp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000684)∆* mutants have no discernable defects in actin organization and only subtle defects in endocytosis ([@bib223]; [@bib190]), double mutants with *[sla1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000103)*, *[sla2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005187)*, or *[sac6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002536)* are lethal ([@bib171]), demonstrating that the functions of [Abp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000684) are important, although genetically redundant. Interestingly, all three shared functions of [Abp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000684) depend on its SH3 domain, but only two of these (shared with [Sla2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005187) and [Sac6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002536)) depend on its ability to bind F-actin ([@bib313]). Recently, [Abp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000684) was found to be essential for an alternative endocytic pathway in yeast, perhaps related to its synthetic lethality with factors central to the conventional CME pathway ([@bib5]). While purified [Abp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000684) alone shows no effects on actin-filament dynamics or organization *in vitro* ([@bib144]; [@bib313]), when bound to its ligand [Aim3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000312) it can cap actin-filament barbed ends ([@bib251]). Through this interaction, and its interactions with the Arp2/3 complex and the other binding partners mentioned above, [Abp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000684) may influence actin-filament assembly and turnover in a number of ways.

### Regulation of actin nucleation in endocytosis: {#s25}

How are the activities of Arp2/3 complex's four NPFs utilized and controlled during endocytosis? As mentioned above, the precise spatial recruitment and/or localized activation of NPFs at endocytic sites is likely to be critical in enabling the polymerizing actin network to provide the appropriate directional force to drive plasma membrane invagination and tubulation. Recent EM studies have begun to define the locations of the NPFs to give us clues to how this works ([@bib179]; [@bib180]). These studies suggest that two different pools of NPFs, one at the plasma membrane ([Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707), [Myo3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001612), and [Myo5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004715)) and the other at the tip of the invagination ([Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445) and [Abp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000684)), might control two different phases of endocytosis, invagination and scission, respectively.

In addition to the proper spatial recruitment of NPFs at endocytic sites, it is critical that their activities be tightly controlled in a temporal manner. [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) and [Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445) are the first NPFs to appear at patches, arriving at least 20 sec before the onset of actin assembly, and subsequently myosin I and [Abp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000684) arrive shortly after the first appearance of F-actin. These observations beg the question, How are early arriving NPFs, [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) and [Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445), kept inactive at endocytic sites until the required onset of actin assembly?

#### Control of early NPF localization and activity: {#s26}

Among the many binding partners of [Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445), so far only [Sla2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005187) has been shown to regulate [Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445) NPF activity, inhibiting its effects *in vitro* ([@bib376]). This may be critical for blocking actin assembly until an endocytic patch has sufficiently matured, although much work is still needed to fully understand [Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445) regulation *in vivo*. In contrast, our understanding of [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) regulation has expanded significantly in recent years. Five direct inhibitors of [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) activity have been identified: [Sla1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000103), [Bbc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003557), [Syp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000626), [Lsb1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003368), and [Lsb2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006358) ([@bib321]; [@bib39]; [@bib352]). [Syp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000626) arrives at patches well before [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707), and [Sla1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000103) arrives in approximately the same time frame as [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707), making these binding partners prime candidates for constraining [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) activity ([@bib189]; [@bib357]). In contrast, [Bbc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003557) arrives later, suggesting that it may have a different role than that of a [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) inhibitor, possibly in spatially restricting [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) activity during vesicle internalization. Finally, the function and localization of [Lsb1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003368) and [Lsb2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006358) are unclear, but overexpressed [Lsb1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003368) redistributes [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) into cytoplasmic puncta, and together with the Ub-ligase [Rsp5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000927) and [Sla1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000103), [Lsb1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003368) is implicated in the regulation of [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) protein levels ([@bib194]; [@bib352]). As mentioned earlier, [Syp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000626) binds and inhibits [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707), which is achieved through its central region ([@bib39]). [Sla1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000103) contains multiple SH3 domains through which it binds to proline-rich motifs in [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) to inhibit its NPF activity ([@bib321]; [@bib111]). [Syp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000626) and [Sla1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000103) also directly associate to form a stable complex in cells and together more effectively block [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) activity *in vitro* ([@bib111]) ([Figure 6A](#fig6){ref-type="fig"}). It should be noted that in biochemical assays testing inhibition of [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707), high ratios of the inhibitors to [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) (likely higher than those found at endocytic sites *in vivo*) are required to block activity. However, this does not rule out the possibility that clustering at the membrane, lipid/scaffold protein binding, and/or post-translational modifications *in vivo* drive these interactions to improve the efficiency of [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) inhibition.

How is inhibition of [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) by [Syp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000626) and [Sla1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000103), and possibly [Lsb1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003368) and [Lsb2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006358), subsequently released to allow actin assembly? The first clue is the observation that [Syp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000626) disappears from patches just before the onset of actin assembly ([@bib39]; [@bib357]). The mechanism for promoting [Syp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000626) departure from patches is unknown, but one possibility is direct phosphorylation by [Ark1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004965) and [Prk1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001357) kinases ([@bib174]; [@bib8]). The second clue is the arrival [Bzz1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001156) a few seconds before the onset of actin assembly ([@bib359]). [Bzz1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001156) binds [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) via its SH3 domains and is predicted to compete with [Sla1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000103) ([@bib351]; [@bib373]). Further, *S. pombe* [Bzz1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001156) stimulates WASP--Arp2/3-mediated actin assembly *in vitro*, and mutants have reduced number of actin patches and impaired patch dynamics ([@bib14]). [Bzz1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001156) dimerizes using its F-BAR domain and thus could elevate [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) NPF activity by organizing two [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) molecules ([Figure 6C](#fig6){ref-type="fig"}). It is tempting to speculate that the combination of [Syp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000626) departing and [Sla1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000103) facing new competition from [Bzz1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001156) is sufficient to trigger [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) release at the base of the invagination, allowing it to recruit Arp2/3 complex and initiate actin assembly. Consistent with this model, mutations in [Bzz1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001156) and myosin I are synthetic lethal ([@bib350]), as are mutations in [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) and myosin I.

Recent studies combining light and electron microscopy have shown that [Bzz1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001156) is recruited to endocytic sites when membrane curvature is low, remains at the base of the invagination, and helps shape the tubule in coordination with the BAR domain proteins [Rvs161](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000602) and [Rvs167](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002796) ([@bib201]). Like F-BAR proteins, [Bzz1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001156) may self-assemble to form a rigid collar at the base of the invagination, providing resistance to actin-assembly forces, while Rvs proteins coat the tubule to help shape the vesicle. [Bzz1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001156) may also locally activate [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) at the base of the invagination, directly coordinating membrane remodeling and actin assembly. Similar roles have been suggested for [Sla2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005187) and [Rvs167](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002796) in coordinating membrane and actin remodeling; [Sla2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005187) links membranes to F-actin, [Sla1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000103), [Vrp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004329), and [Ysc84](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001058), while [Rvs167](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002796) links membranes to [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707), [Ysc84](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001058), [Abp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000684), and [Aim3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000312).

#### The search for Eve: the first mother filament: {#s27}

Even after [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) is activated, there is another requirement for initiation of an actin network by Arp2/3 complex, which is a first mother filament, or alternatively a mechanism for bypassing the requirement of a first filament. Two different models have been put forth to explain how this might be achieved. First, it has been suggested that short filament fragments produced by severing events at nearby patches or cables may diffuse to new sites of endocytosis and be captured to prime network assembly. This model is supported by one recent study analyzing the effects of cofilin mutants on patch formation ([@bib69]). Second, it has been postulated that there is specialized machinery at patches that either (a) induces conformational changes in Arp2/3 complex similar to mother filament binding or (b) recruits and organizes actin monomers into a short F-actin seed that serves as the primer ([Figure 6B](#fig6){ref-type="fig"}). In this regard, as noted above, full-length [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) has NPF activity at least 2 orders of magnitude stronger than just its VCA region ([@bib321]), suggesting that other domains in [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) might contribute to such a function. Further, the Las17-binding partner [Ysc84](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001058)/[Lsb4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001058) binds F-actin and together with [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) (no Arp2/3) can stimulate actin polymerization ([@bib318]). Further the *S. pombe* WISH/DIP/SPIN90 ortholog Dip1 ([Ldb17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002305) in *S. cerevisiae*) binds Arp2/3 complex and stimulates *unbranched* nucleation, suggesting that *in vivo* it may trigger formation by Arp2/3 complex of the first mother filament to initiate actin network assembly, a model that is strongly supported by analysis of its mutant phenotype ([@bib25]). Interestingly, [Ldb17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002305) has interactions with [Sla1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000103), [Bzz1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001156), and [Ysc84](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001058)/[Lsb4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001058), which further suggests that a number of these factors may contribute to a multicomponent regulatory mechanism controlling both the initial restraint and subsequent activation of actin network formation.

#### Orchestration of multiple NPFs: {#s28}

The next NPFs to arrive at sites of endocytosis, after [Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445) and [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707), are [Vrp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004329) and myosin I, in that order. Live-imaging analysis has shown that [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) recruits [Vrp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004329), which together with F-actin in turn recruits myosin I to patches ([@bib350]; [@bib186]; [@bib339]; [@bib359]). Current models suggest that myosin I remains anchored to the plasma membrane, while its nucleation activity and motor activity cooperate to produce directional force in facilitating membrane remodeling. Specifically, its barbed end-directed motor activity at the base of the invagination could provide an inward force on the entire actin network to drive tubulation. To facilitate this step, there may be patch components that help cluster and anchor myosin I at the base; one candidate for this role is [Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445), which binds myosin I through its C-terminal proline-rich domain (PRD) and increases the combined NPF activity of myosin I and [Vrp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004329) ([@bib23]). How the motor activity of myosin I is coordinated with its NPF effects and if/when myosin I functions in a complex with [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) remain open questions. [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) and myosin I activities also may not be restricted to the base of the patch, as originally thought, since more recent studies (using new tags that are possibly more functional) suggest that [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) and myosin I might be positioned not only at the base of the patch but also at the tip of the invagination ([@bib179]; [@bib180]). What role these NPFs play at the tip of the invagination is unclear, but may involve molding the tubular invaginations into more bulbous vesicles ([@bib209]).

Last to arrive at patches is [Abp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000684), another poorly understood NPF. *[abp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000684)* mutants show a pattern of genetic interactions with other NPFs and *[arp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002187)* alleles that suggests an antagonistic relationship with class I NPFs ([@bib83]). Consistent with this model, purified [Abp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000684) competes directly with [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) VCA region for binding Arp2/3 complex and attenuates VCA stimulatory effects. However, this may not be the full extent of [Abp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000684)'s Arp2/3-regulating functions. Much like myosin I, which had little effect on Arp2/3 activity until it was combined with its ligand [Vrp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004329) ([@bib359]), [Abp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000684) may have important effects on Arp2/3 complex that require the presence of other NPFs and/or [Abp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000684) binding partners.

Actin-filament capping, cross-linking, and stabilization {#s29}
--------------------------------------------------------

Once nucleated, daughter filaments in the actin network must be capped rapidly at their barbed ends to (a) restrict filament length and produce a network consisting of densely branched, short interconnected filaments and (b) maintain the actin monomer pool in cells to support rapid growth at new sites of nucleation ([@bib230]; [@bib36]) ([Figure 4](#fig4){ref-type="fig"}). Thus, barbed end capping plays an instrumental role in enabling networks to generate directional force applied to membrane protrusion in motility and membrane invagination in endocytosis. In addition to being capped, newly formed filaments are decorated along their sides by a number of actin-associated proteins that stabilize, crosslink, and/or bundle F-actin. These proteins may be critical for holding the network together, and for transferring mechanical forces from actin polymerization and myosin activity across the network to deform the membrane ([@bib56]).

### Filament capping: {#s30}

For years, it was presumed that capping of Arp2/3 complex-generated branched networks was mediated solely by heterodimeric "capping protein," [Cap1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001490)/[Cap2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001296) (CP), which has a well-defined structure and interactions with the filament end (reviewed in [@bib79]). However, this left the nagging question---Why do mutations in CP cause only minor defects in actin patch organization or dynamics ([@bib9]; [@bib200])? New insights into this question have emerged from genetic and biochemical studies demonstrating that the combination of the disassembly factors [Aip1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004698) and [Cof1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003973) (see below) blocks barbed end growth ([@bib280]) and that mutations in CP and [Aip1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004698) are synthetic lethal ([@bib20]). Further, as mentioned above, a recent study showed that the combination of [Abp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000684) and its ligand [Aim3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000312) caps barbed ends and that mutations in either [Abp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000684) or [Aim3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000312) display synthetic genetic interactions with CP and [Aip1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004698) ([@bib251]). In addition, this study showed that CP and [Aip1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004698) localize to distinct regions of actin networks (newer and older, respectively, as visualized in the elongated actin structures of *[sla2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005187)∆* mutants) and that when CP is deleted [Aip1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004698) spreads into CP territory. Further, a complementary study in *S. pombe* shows that CP spreads into [Aip1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004698) territory when [AIP1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004698) is deleted ([@bib31]). Thus, actin patches have at least three different barbed end-capping mechanisms (CP, [Aip1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004698)--[Cof1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003973), and [Abp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000684)--[Aim3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000312)), although there is much more to learn about their specific roles and mechanisms.

Intriguingly, the phosphoinositide PtdIns(4,5)P~2~ (which is critical for endocytosis; see *Vesicle Scission and Uncoating*) can weaken interactions between CP and barbed ends in other systems ([@bib332]). Since barbed ends are thought to face the membrane at the base of the endocytic invagination, protection against capping at these locations by PtdIns(4,5)P~2~ could allow polymerization toward the membrane and thus direct expansion of the actin network in the right orientation.

### Filament bundling: {#s31}

Different F-actin crosslinking proteins can organize filaments into parallel and antiparallel bundles or orthogonal arrays, giving rise to networks of filaments with distinct geometries and mechanical properties ([@bib24]; [@bib307]). Yeast cells have at least five different actin crosslinking proteins that potentially regulate the spatial organization of filaments at sites of endocytosis, [Sac6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002536)/fimbrin, [Scp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005894)/calponin, [Abp140](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005765), [Crn1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004421), and [Tef1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006284)/[Tef2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000322), each discussed in detail below. As mentioned above, it is not yet clear where crosslinking of filaments occurs within the presumably densely branched actin patch networks. One possibility is that debranching effects rapidly remodel specific regions of a patch (see below), and then crosslinking proteins reorganize filaments into bundles or orthogonal arrays. Another possibility is that crosslinks are added to reinforce connections among already branched filaments, providing additional mechanical strength to the network (as illustrated in [Figure 4](#fig4){ref-type="fig"}). Since at least five crosslinking proteins potentially act on distinct regions of an actin patch, they may function during specific temporal phases as the patch matures, elongates, and moves away from the plasma membrane. Further, their individual activities may help generate distinct architectural zones within the network during any given phase.

#### Sac6/fimbrin: {#s32}

[Sac6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002536) was first isolated from yeast-cell extracts on F-actin affinity columns ([@bib96]) and in parallel in genetic screens as a suppressor of an *[act1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001855)* allele ([@bib2]). It is the yeast homolog of the widely expressed protein fimbrin, which bundles filaments into parallel arrays *in vitro* ([@bib47]; [@bib137]). The crystal structures of *Arabidopsis thaliana* and *S. Pombe* fimbrin show that it consists of four tandem calponin homology (CH) domains organized into two separate actin-binding units ([@bib202]). The 3D reconstructions from electron micrographs of fimbrin-decorated F-actin bundles suggest a regular pattern of crosslinks with a specific geometry ([@bib157]; [@bib390]). However, there is currently only limited evidence to support a role for yeast [Sac6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002536) functioning as a bundler *in vivo*. One study found that a truncated *S. pombe* [Sac6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002536)/fimbrin defective in bundling F-actin *in vitro* failed to rescue fimbrin function at actin patches *in vivo* ([@bib344]), suggesting that bundling might be essential for fimbrin *in vivo* function. However, this truncation mutant reduced actin-binding affinity, leaving open alternative interpretations. There are at least two other biochemical activities of [Sac6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002536)/fimbrin: (i) F-actin stabilization and (ii) competitive inhibition of tropomyosin decoration of F-actin at patches ([@bib145]; [@bib343]). Thus, more work is needed to determine conclusively whether [Sac6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002536)/fimbrin, or any of the other *in vitro* bundling proteins (below), actually crosslink filaments *in vivo* at actin patches.

#### Scp1/calponin: {#s33}

[Scp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005894) is the yeast homolog of the mammalian actin-bundling protein calponin (22 kDa), also referred to as SM22 or transgelin. Vertebrate genomes contain three calponin genes, which have important functions in both muscle and nonmuscle cells ([@bib327]; [@bib415]). Yeast [Scp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005894) is composed of an N-terminal CH domain, a short proline-rich segment, and a single C-terminal calponin-like repeat (CLR). Although CH domains bind actin in many proteins (*e.g.*, [Sac6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002536)/fimbrin and α-actinin), the CH domain of calponin does not ([@bib145]) and instead may bind microtubules and/or other ligands ([@bib327]). The C-terminal half of [Scp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005894) mediates actin bundling and harbors two distinct actin-binding sequences, one in the proline-rich region and one in the CLR ([@bib145]; [@bib412]; [@bib136]). Although *[scp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005894)∆* mutants alone do not cause obvious defects in actin organization or endocytosis, *[scp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005894)∆ [sac6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002536)∆* double mutants exhibit gross abnormalities in cell size, actin organization, and endocytosis, far more severe than defects in *[sac6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002536)∆* mutants ([@bib145]). Further, overexpression of [Scp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005894) partially rescues the single-mutant defects of *[sac6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002536)∆*. Together, these observations suggest that [Scp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005894) and [Sac6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002536) perform related, overlapping functions *in vivo*, which is consistent with biochemical observations showing that each protein bundles and stabilizes F-actin. [Sac6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002536) is also upregulated in *[scp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005894)∆* mutants, which may explain why the *[scp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005894)∆* phenotype is not stronger ([@bib136]). Live-cell imaging analysis has revealed that [Scp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005894) helps promote inward movement of patches from the plasma membrane ([@bib136]). These observations raise the intriguing possibility that [Scp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005894) and [Sac6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002536) play a role in further crosslinking Arp2/3-generated branched networks and stiffened them to facilitate myosin I-dependent force transmission during invagination and scission.

#### Abp140: {#s34}

[Abp140](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005765) was isolated from yeast cell extracts in an assay for novel F-actin bundling factors, and localizes to both actin patches and cables ([@bib15]). Although its molecular weight is 70 kDa, it was initially thought to have a molecular weight of 140 kDa (likely due to disulfide bond formation), giving rise to its name. To date, [Abp140](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005765)--GFP has provided the only effective marker for live-cell imaging of actin cables ([@bib417]). In fact, the popular actin marker Lifeact, used to label actin in live-cell imaging studies in a wide range of organisms, is a small peptide derived from [Abp140](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005765) ([@bib317]). Because *[abp140](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005765)∆* causes no obvious change in actin organization or dynamics, its role in the actin cytoskeleton may be redundant with other actin-binding proteins, but this has not been explored genetically. More recent studies have revealed that in addition to binding actin, [Abp140](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005765) is a methyltransferase that modifies the tRNA anticodon loop ([@bib97]; [@bib277]). Further, [ABP140](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005765) mRNA is tethered to nascent [Abp140](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005765) protein, which binds actin and moves rapidly with actin cable retrograde flow to reach the back of the mother cell, accumulating at this pole ([@bib199]). These observations provide intriguing new links between actin and protein translational control, adding to the wealth of previous observations connecting actin and translation ([@bib167]).

#### Crn1: {#s35}

[Crn1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004421) is the yeast homolog of coronin and binds with high affinity to F-actin and homo-oligomerizes via its C-terminal coiled-coil domain to crosslink actin filaments *in vitro* ([@bib143]). The actin-binding surfaces on [Crn1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004421)'s N-terminal β-propeller domain have been mapped to evolutionarily conserved residues and are required for its shared genetic functions with [Cof1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003973) ([@bib128]). Genetic interactions for *[crn1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004421)∆*, as well as the late arrival of [Crn1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004421) to actin patches ([@bib225]), suggest that its primary role in actin regulation may be to promote turnover (see below); thus, more work is needed to determine whether the actin crosslinking activity is relevant to [Crn1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004421)'s *in vivo* functions.

#### Tef1/Tef2: {#s36}

[Tef1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006284) and [Tef2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000322) are the yeast homologs of protein translation elongation factor eEF1A (formerly known as eEF1α), which is one of the most abundant proteins in eukaryotic cells and delivers aminoacyl-tRNA to translating ribosomes. [Tef1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006284) and [Tef2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000322) are identical in sequence and genetically redundant. In addition to its canonical role, [Tef1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006284)/[Tef2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000322)/eEF1A has an important role in F-actin bundling ([@bib269]; [@bib268]). This function depends on a specific actin-binding surface, and mutations at this site abolish actin interactions without affecting protein translation ([@bib150]). Using these alleles, it was shown that Tef1-actin interactions are important for the proper formation of actin cables, which is also consistent with reported interactions between [Tef1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006284) and the formin [Bni1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005215) ([@bib379]). Because of its abundance in the cytosol, it has been difficult to determine whether a subpopulation of [Tef1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006284) localizes to cables and/or patches, and there have been no investigations into the potential role of [Tef1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006284) in endocytosis.

Actin-filament disassembly and turnover {#s37}
---------------------------------------

About 3--7 sec after actin assembly is initiated at the cortical patches, components of the disassembly and turnover machinery begin arriving ([@bib282]; [@bib225]). During the next 10--15 sec of the actin patch lifetime, there is continued actin assembly, likely concurrent with disassembly, which predicts a highly dynamic actin network. Maintaining a high rate of turnover may endow the actin network with plasticity, which may be especially important in processes such as endocytosis and lamellipodial protrusion, where the shape of the actin network changes dramatically with membrane invaginations or protrusions. In endocytosis, the shape and architecture of the actin network is likely to change drastically over the course of its 15-sec lifespan ([Figure 1, G and H](#fig1){ref-type="fig"}). Based on the measured rate of actin turnover in extended cortical actin patches (0.05 µm sec^−1^, or about 70 subunits sec^−1^) ([@bib189]), it is possible that the entire F-actin content of a patch turns over three to four times during the patch lifetime. This begs the question---What are the mechanisms that enable such rapid actin turnover, and how are they balanced with new actin assembly, to maintain a network of a particular size while allowing it to rapidly evolve in shape and architecture?

From knowledge gained over the past 17 years, an answer to the question above is that actin-filament turnover is controlled by two major factors: (i) the changing nucleotide state (age) of filaments and (ii) a complex set of machinery that responds to these changes and works collectively to efficiently dismantle older regions of filaments without affecting newer regions. Below, we first discuss the nucleotide state of F-actin and the components of the actin turnover machinery ([Figure 7](#fig7){ref-type="fig"}) and then provide an overview of their combined mechanisms in F-actin severing and depolymerization and G-actin recycling ([Figure 4](#fig4){ref-type="fig"}).

![Actin turnover machinery. Scheme showing the proteins that regulate actin-filament debranching, filament severing and depolymerization, and monomer recycling. Dotted lines are physical interactions. Numbers correspond to the designated steps in actin turnover in which each protein participates.](315fig7){#fig7}

### The nucleotide state of actin: {#s38}

Critical to the control of F-actin disassembly is the age of the filament, specified by its nucleotide state ([@bib308]; [@bib92]). When each ATP-actin monomer is added to the barbed end of a filament, its noncovalently bound ATP undergoes very rapid hydrolysis to generate ADP and inorganic phosphate (*P*~i~). Hydrolysis occurs at a rate of 0.3 sec^−1^ for rabbit muscle actin, and possibly much faster for yeast actin ([@bib49]). The products remain bound to actin, as ADP + *P*~i~-actin, and then in a subsequent and slower step, *P*~i~ is released from the filament to yield ADP-actin. The rate of *P*~i~ release for muscle actin is 0.0022 sec^−1^, but has not been measured for yeast actin. Recent results show that each subunit in a filament formed by muscle actin releases P~i~ independently, without influence from its neighboring subunits ([@bib185]). Thus, each filament is thought to be a unique mosaic of subunits in different nucleotide states, with the growing end of the filament enriched in ATP and ADP + *P*~i~-actin, and the older end of the filament enriched in ADP-actin. The relative amounts and distribution of each form of actin will depend on at least four factors: (a) the filament length, (b) the filament growth rate, (c) the species-specific rate constants for hydrolysis and *P*~i~ release, and (d) the influence of actin-binding proteins on these rates. Importantly, F-actin in each nucleotide state has a distinct conformation, which endows it with different dynamic properties and recruits a different set of actin-associated proteins ([@bib92]). One unanswered question is what portion of a yeast endocytic actin network exists in each nucleotide state, but this is difficult to answer in the absence of more information on points c and d above. Clearly, this is an area ripe for future investigation.

### The actin turnover machinery: {#s39}

Below, we discuss individually each of the seven known, and highly conserved, components of the actin turnover machinery ([cofilin](http://www.yeastgenome.org/locus/S000003973/overview), [GMF](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002470), [Aip1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004698), [coronin](http://www.yeastgenome.org/locus/S000004421/overview), [Srv2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005082)/[CAP](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005082), [profilin](http://www.yeastgenome.org/locus/S000005648/overview), and [twinfilin](http://www.yeastgenome.org/locus/S000003312/overview)), focusing on their protein structures, biochemical activities, and mutant phenotypes in yeast. We then discuss how the activities of these components are orchestrated to facilitate each step in actin turnover ([Figure 4](#fig4){ref-type="fig"} and [Figure 7](#fig7){ref-type="fig"}).

#### Cof1: {#s40}

Cofilin, also called ADF, is one of the more abundant actin-associated proteins in yeast and mammalian cells. It is an 18-kDa globular protein that binds with higher affinity to ADP-actin monomers and filaments and lower affinity to ATP-actin (reviewed in [@bib284]). Cofilin binds cooperatively to F-actin ([@bib35]), leading to an uneven pattern of decoration that can be visualized by two-color TIRF microscopy ([@bib358]; [@bib66]). Decoration by cofilin "twists" filaments ([@bib242]) and causes major conformational rearrangements ([@bib122]). Severing occurs at the boundaries between cofilin-decorated and undecorated regions on filaments due to mechanical discontinuities ([@bib358]). However, it remains to be seen how the severing mechanism is affected when cofilin functions in concert with other actin disassembly factors (below). The *[COF1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003973)* gene is essential ([@bib257]), but partial loss-of-function *[cof1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003973)* alleles generated by scanning mutagenesis ([@bib213]) show defects in patch dynamics just before scission, pointing to an important role for cofilin-mediated actin turnover and remodeling in driving invagination ([@bib212]; [@bib282], [@bib283]; [@bib225]). Additional defects are observed at later stages of endocytosis, including a delayed uncoating of actin from internalized vesicles.

#### Gmf1: {#s41}

[Gmf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002470), the yeast homolog of mammalian [GMF](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002470) (glia maturation factor), is an 18-kDa protein with structural similarity to cofilin ([@bib146]). [GMF](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002470) is one of four proteins in the ADFH domain superfamily conserved from yeast to humans: [cofilin](http://www.yeastgenome.org/locus/S000004421/overview), [Abp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000684), [twinfilin](http://www.yeastgenome.org/locus/S000003312/overview), and [GMF](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002470) ([@bib310]). [Gmf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002470) has little if any binding affinity for F-actin, but binds strongly to Arp2/3 complex ([Figure 7](#fig7){ref-type="fig"}) and genetically interacts with cofilin suggesting a role in turnover ([@bib182]; [@bib129]; [@bib270]). [Gmf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002470) catalyzes debranching of filaments *in vitro* without severing filaments at nonbranch locations ([@bib129]). The debranching activity of yeast [Gmf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002470) is conserved in *Drosophila* and mouse GMFs ([@bib311]) and depends on separate binding interactions with Arp2 and the first actin subunit in the daughter filament, suggesting a modified cofilin-like severing mechanism for debranching ([@bib232]; [@bib419]). [GMF](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002470) preferably binds to ADP-rather than ATP-Arp2/3 complex ([@bib37]), suggesting that it targets "aged" branches. [GMF](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002470) also inhibits Arp2/3-mediated actin nucleation by competing with VCA for binding Arp2/3 ([@bib129]; [@bib270]; [@bib419]). The *in vivo* relevance of this latter activity is unclear, but could help inhibit branched nucleation by Arp2/3 complex in the absence of NPFs or suppress branched nucleation at the older (ADP-rich) regions of networks to allow filament crosslinkers to act.

#### Aip1: {#s42}

[Aip1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004698) (actin-interacting protein 1) was first identified in a two-hybrid screen for novel interaction partners of yeast actin ([@bib11]) and subsequently as a binding partner of cofilin ([@bib320]). A deletion of *[AIP1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004698)* causes only mild phenotypes, but is synthetic lethal with specific *[cof1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003973)* alleles. Purified [Aip1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004698) alone has no effect on actin-filament dynamics, but in combination with cofilin promotes the net disassembly of F-actin into monomers and short oligomers ([@bib279]; [@bib320]; [@bib283]). The mechanism underlying these effects is thought to involve enhanced severing and blocking barbed end growth at severed ends ([@bib280]; [@bib20]; [@bib285]; [@bib48]; [@bib377]; [@bib251]). [Aip1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004698) consists of two β-propellers in one polypeptide chain and its structure has an open clamshell appearance ([@bib389]; [@bib256]) ([Figure 7](#fig7){ref-type="fig"}). The actin- and cofilin-binding surfaces on [Aip1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004698) have been defined by mutagenesis ([@bib256]; [@bib74]; [@bib281]) and are required for [Aip1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004698) functions *in vivo* in promoting rapid turnover of actin patches and cables ([@bib281]; [@bib283]). Purified [Aip1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004698) binds weakly to F-actin unless it is decorated with cofilin ([@bib279]; [@bib320]; [@bib256]; [@bib281]), and [Aip1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004698)--GFP recruitment to actin patches *in vivo* depends on cofilin ([@bib225]). Recent biochemical, structural, and cell biological evidence has suggested that [Aip1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004698) may enhance severing by competing with [Cof1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003973) for its second binding site on F-actin, leading to filament destabilization. Indeed, in support of this model, mutants in *[cof1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003973)* that disrupt its second F-actin binding site were found to be hyperactive for filament severing ([@bib3]).

#### Crn1: {#s43}

[Crn1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004421), the yeast homolog of coronin, binds with high affinity to ATP-F-actin and much lower affinity to ADP-F-actin ([@bib143]; [@bib52]; [@bib127]). It contains an N-terminal β-propeller domain ([@bib13]), a central unique sequence (highly distinct across distant species) and a C-terminal coiled-coil domain, through which most coronins trimerize ([@bib86]) ([Figure 7](#fig7){ref-type="fig"}). [Crn1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004421) has two separate actin binding sites, one in its β-propeller domain ([@bib128]) and another in its coiled-coil domain ([@bib127]). A *[crn1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004421)∆* mutation alone causes no obvious defects in actin organization or endocytosis ([@bib161]; [@bib143]), but exhibits synthetic genetic interactions with *cof1-22* and *act1-159* alleles, suggesting a role in actin turnover ([@bib143]; [@bib127]). Consistent with this view, purified [Crn1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004421) promotes severing of ADP--actin filaments by cofilin *in vitro* ([@bib127]), and in mammalian systems, coronin, cofilin, and [Aip1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004698) have been coisolated from cell extracts as a three-component system that promotes the rapid disassembly of ADP-filaments ([@bib48]; [@bib207]). The mechanisms underlying these effects for either yeast or mammalian coronins are not yet defined and require further investigation. Adding to the potential complexity of coronin's roles in actin turnover are the interactions of its unique sequence and C-terminal coiled-coil domain with Arp2/3 complex ([@bib178]; [@bib228]).

#### Srv2: {#s44}

[Srv2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005082), also called [CAP](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005082) (cyclase-associated protein), was discovered in yeast as a suppressor of a hyperactivated *ras* allele and as a binding partner of membrane-associated adenylate cyclase ([@bib110]; [@bib114]). [Srv2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005082)/[CAP](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005082) is a bifunctional protein. Its N-terminal half (N-Srv2) hexamerizes into shuriken-like structures that associate with cofilin-decorated F-actin and improve the efficiency of severing ([@bib278]; [@bib66]) ([Figure 4](#fig4){ref-type="fig"} and [Figure 7](#fig7){ref-type="fig"}). Point mutations in N-Srv2 that abolish the enhanced severing activity *in vitro* also cause striking defects in actin organization *in vivo*. In contrast to these functions, the C-terminal half of the protein (C-Srv2) binds to G-actin, and has high affinity for ADP-G-actin (*K*~d~ 18 nM) but 100-fold lower affinity for ATP-G-actin ([@bib241]). This enables C-Srv2 to potently catalyze recycling of cofilin from ADP-actin monomers and nucleotide exchange on actin (ATP for ADP). These activities depend on the coordinated effects of two separate actin-binding sites in C-Srv2, and mutations that disrupt these G-actin interactions *in vitro* also cause defects in actin organization *in vivo* ([@bib241]; [@bib65]). C-Srv2 also has a binding site for profilin, which may enable [Srv2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005082) and profilin to work together in monomer recycling ([@bib33]). One recent study showed that the functions of the N and C termini of [Srv2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005082) are autonomous, such that the two physically separated halves can function in *trans* both *in vitro* and *in vivo* ([@bib67]). However, it was suggested that linkage of the two halves in a single polypeptide may be important for coordinating the two activities *in vivo*. Finally, the structure, activities, and mechanism of this protein were recently shown to be strikingly similar between the yeast and mammalian homologs of [Srv2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005082)/[CAP](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005082) ([@bib278]; [@bib184]), demonstrating that its roles in actin regulation have been conserved in evolution.

#### Profilin: {#s45}

Profilin is a conserved 15-kDa protein that binds preferentially to ATP-actin monomers and also catalyzes nucleotide exchange on actin (ATP for ADP) ([@bib34]; [@bib100]; [@bib20]). Profilin suppresses spontaneous nucleation of actin and blocks monomer addition to pointed ends while freely allowing addition to barbed ends. As a result, profilin helps to restrict new actin growth *in vivo* to barbed ends generated by nucleation mechanisms. Profilin also binds to specific polyproline-rich tracts in other actin regulatory proteins, such as formins and [Srv2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005082) ([@bib60]; [@bib33]) ([Figure 4](#fig4){ref-type="fig"} and [Figure 7](#fig7){ref-type="fig"}). The best understood interaction of profilin is with formins, where it plays a critical role in delivering actin monomers to accelerate barbed end elongation. ([@bib204]; [@bib296], [@bib297]). The actin- and polyproline-binding surfaces on profilin are well defined ([@bib334]; [@bib100]), and mutations at these sites in yeast profilin (*[PFY1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005648)*) cause severe depolarization and misorganization of actin structures ([@bib155]; [@bib414]; [@bib231]), including a striking loss of actin cables, consistent with its role in formin-mediated actin assembly ([@bib331]; [@bib204]). Further, at least one of the actin-binding-deficient *[pfy1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005648)* mutants displays defects in fluid-phase endocytosis ([@bib414]). Since there is no evidence supporting a role for profilin in promoting Arp2/3-dependent assembly of branched actin-filament networks at sites of endocytosis, the potential connections between *[PFY1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005648)* and endocytosis have remained elusive. However, one possibility is that the loss of actin cables resulting from mutations in profilin indirectly compromises endocytosis. Finally, it should be noted that profilin binds PtdIns(4,5)P~2~ and that this interaction competes with actin binding, raising the possibility that local changes in membrane composition influence profilin's effects on the actin cytoskeleton ([@bib215]; [@bib286]).

#### Twf1: {#s46}

[Twf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003312) (or twinfilin) was identified in yeast both on F-actin affinity columns and in database searches for proteins with homology to [Cof1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003973) ([@bib142]). Twinfilin is composed of two ADFH domains connected by a short linker sequence and has a short C-terminal tail region ([Figure 7](#fig7){ref-type="fig"}). Studies on yeast and mouse twinfilin have shown that the N-terminal ADFH domain binds G-actin, whereas the C-terminal domain binds G- and F-actin ([@bib288]; [@bib164]; [@bib289]; [@bib290]). In addition, the C-terminal tail of yeast twinfilin binds to CP, and this interaction is critical for [Twf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003312) localization to actin patches and [Twf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003312)'s shared genetic functions with [Cof1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003973) ([@bib293]; [@bib107]). However, [Twf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003312) has no detectable effect on CP activity *in vitro*, nor does CP have any detectable effects on [Twf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003312) interactions with G-actin, which has left the functional role of the [Twf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003312)--CP interaction unclear. Yeast and mammalian twinfilin proteins bind with high affinity to ADP-G-actin and suppress monomer addition to filament ends ([@bib142]; [@bib385]), which led to early models suggesting that twinfilin serves primarily as an actin monomer sequestering protein similar to thymosin-β4 ([@bib294]; [@bib310]). However, other lines of evidence have pointed to twinfilin-promoting actin-filament disassembly or turnover, including: (i) twinfilin genetically interacts with cofilin in yeast and flies ([@bib142]; [@bib394]); (ii) genetic perturbation of twinfilin in yeast cells slows actin turnover, and in mammalian cells slows cell motility ([@bib260]; [@bib246]; [@bib395]); (iii) twinfilin localizes to sites of dynamic actin turnover in these systems: patches in yeast, and the leading edge or endosomal actin tails in mammalian cells ([@bib293]; [@bib163]); (iv) the C-terminal ADFH domain in twinfilin binds F-actin in addition to G-actin and can interact with the barbed end of the filament ([@bib289]); and (v) [Twf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003312) associates with the actin turnover-promoting protein [Srv2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005082) *in vivo* ([@bib367]; [@bib45]). Thus, we have included twinfilin here, with the other actin turnover machinery; however, the specific role and mechanism of twinfilin in promoting turnover remains a mystery.

### Coordinated mechanisms of actin-filament disassembly and turnover: {#s47}

Actin patches are highly dynamic structures, in which filaments are being rapidly assembled and disassembled concurrently, and the entire network turns over as rapidly as every 3-4 sec (see above). Here, we discuss the process of branched actin-filament network disassembly, which mechanistically can be broken down into three steps, discussed below: debranching, severing and depolymerization, and monomer recycling.

#### Debranching: {#s48}

Quantitative studies in *S. cerevisiae* and *S. pombe* suggest that each actin patch contains approximately 5000--7000 actin subunits and 100--300 Arp2/3 complexes and capping proteins ([@bib225]; [@bib340]). Based on these numbers, the actin networks at endocytic sites are predicted to consist of very short filaments with frequent branch points (one branch per 35--50 actin subunits), consistent with EM studies ([@bib422]; [@bib323]). The Arp2/3 complex--actin filament junction is a specialized structure with a unique F-actin conformation ([@bib326]) and thus may require specialized mechanisms for inducing its destabilization. The branches generated by purified actin and yeast Arp2/3 complex are extremely stable for at least 10 min ([@bib129]), whereas *in vivo* they may be turned over every 3--4 sec. How is this achieved? One factor that influences debranching is the nucleotide state of the [Arp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002187) and [Arp3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003826) subunits in Arp2/3 complex. ATP binding (but not hydrolysis) on [Arp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002187) and [Arp3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003826) is required for nucleation, and then hydrolysis is thought to occur right after nucleation, which influences debranching ([@bib240], [@bib239]; [@bib183]). Importantly, hydrolysis is not sufficient to promote debranching; additional factors are required. As mentioned above, [Gmf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002470) is a dedicated debranching factor that targets ADP-Arp2/3--actin junctions ([@bib129]; [@bib37]; [@bib419]), and cofilin catalyzes debranching through its ability to bind the sides of ADP-F-actin ([@bib59]). Whether [Gmf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002470) and [Cof1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003973) biochemically cooperate in debranching has not yet been tested, but would be consistent with their genetic interactions ([@bib129]; [@bib270]). A third factor that may contribute to debranching is [Crn1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004421), which like [Gmf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002470) binds Arp2/3 complex ([Figure 7](#fig7){ref-type="fig"}) and shifts the conformational distribution of the Arp2/3 complex toward the open (inactive) state ([@bib178]; [@bib322]; [@bib419]). These similarities between [Crn1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004421) and [Gmf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002470), along with the suggestion that mammalian Coronin-1B promotes debranching ([@bib53]), make [Crn1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004421) a promising candidate for participating in pruning daughter filaments.

#### Filament severing and disassembly: {#s49}

How is the filamentous content of an actin patch disassembled and turned over in seconds? As mentioned above, the nucleotide state of actin is paramount in controlling turnover, and the conversion of newer (ATP or ADP + *P*~i~) actin to aged (ADP) actin determines what regions of a network are targeted for demolition. At the center of the filament disassembly process is cofilin. *[COF1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003973)* is an essential gene and is *required in vivo* for the rapid turnover of actin patches ([@bib212]). However, an important but often overlooked fact is that cofilin, while essential, is not *sufficient* to support rates of actin turnover necessary for cell viability. This is evident from genetic observations defining lethal pairs of other actin disassembly factor mutants, including *[srv2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005082)∆* and *[aip1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004698)∆* ([@bib20]). As described above, there is now strong evidence for at least four other highly conserved actin-binding proteins (coronin, [Srv2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005082), [Aip1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004698), and [Gmf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002470)), and possibly [Twf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003312), functioning in concert with cofilin to catalyze severing and disassembly through a complex multicomponent mechanism ([Figure 7](#fig7){ref-type="fig"}). Thus, cofilin should be viewed as one essential component of a larger ensemble that decorates filaments and induces rapid severing and disassembly. At actin patches, the products of enhanced severing are envisioned to be very short oligomers of F-actin, blocked at their barbed ends from further monomer addition either by physical obstruction of the end or conformational changes in F-actin mediated by disassembly factors. These short F-actin fragments would depolymerize into ADP-monomers (many of which should be cofilin bound) as a result of pointed end dissociation. This step is inherently slow in purified F-actin, so it will be important to determine whether it can be accelerated by one or more of the disassembly factors ([Figure 7](#fig7){ref-type="fig"}).

#### Monomer recycling: {#s50}

The process of actin-filament disassembly produces a rapid and continuous flow of cofilin-bound ADP-actin monomers, and possibly free ADP-actin monomers, which must be rapidly converted back to ATP-actin to enable new rounds of filament growth. The free ADP-actin monomers can be readily recycled due to the inherently fast rate of nucleotide exchange of G-actin, and this step can be accelerated further by binding of profilin or [Srv2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005082) ([@bib20]; [@bib65]). However, the cofilin-bound ADP-actin monomers pose a much greater barrier to recycling for multiple reasons. First, cofilin strongly suppresses nucleotide exchange. Second, cofilin and profilin competitively bind G-actin. Third, cofilin binds with at least 20-fold higher affinity than profilin to ADP-G-actin ([@bib100]; [@bib35]). Indeed, profilin has minimal effects in promoting nucleotide exchange on cofilin-bound ADP-actin *in vitro* ([@bib65]). In addition, plant profilins fail to catalyze nucleotide exchange on actin even in the absence of cofilin ([@bib64]), and yeast profilin has much weaker nucleotide exchange activity than mammalian profilin. In contrast, [Srv2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005082) exhibits a very high affinity for ADP-G-actin (20 nM) and readily displaces cofilin from ADP-actin monomers to efficiently catalyze the conversion of cofilin-bound ADP-actin to ATP-actin. Further, it has a binding site for profilin, which may enable profilin and [Srv2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005082) to work together in promoting nucleotide exchange ([Figure 4](#fig4){ref-type="fig"}) and/or facilitate loading of profilin onto ATP-actin monomers to more rapidly replenish the assembly-competent monomer pool. More work is needed to determine the molecular mechanisms by which these, and possibly other factors, work in concert to control rapid recycling of actin monomers.

Vesicle Scission and Uncoating {#s51}
==============================

The process of remodeling lipid membranes for invagination and scission at endocytic sites is intimately tied to lipid composition and dynamic lipid modifications. Changes in membrane shape rely on force generation by the actin cytoskeleton and are mediated by physical connections between the membrane, coat, and actin network. The role of the membrane and the functions of interacting machinery during endocytosis is an area of intense current investigation, likely to yield many new insights in the coming years. Below we summarize what is known about the roles played by specific lipids in this process. The interested reader is referred to recent literature that provides a more in-depth discussion of the currently understood roles of lipids and lipid-binding proteins that are hypothesized to mediate vesicle scission ([@bib201]; [@bib209]; [@bib347]).

The uncoating process is dominated by protein kinases that phosphorylate the coat proteins, disrupt their interactions, and thus promote disassembly. As summarized below, uncoating is necessary to recycle the coat proteins for subsequent rounds of endocytosis, as well as to create coat-free zones on the vesicle surface and thus allow contact and fusion with endosomes.

Roles for lipids and vesicle scission in endocytosis {#s52}
----------------------------------------------------

### Sphingolipids and sterols: {#s53}

The first link between endocytosis and sphingolipids in yeast came from the discovery that a mutation in the long-chain base biosynthetic enzyme [Lcb1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004911) caused endocytic defects ([@bib265]). Subsequently, it was shown that [Pkh1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002898)/2 (sphingolipid-stimulated protein kinases) and [Ypk1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001609)/2 ([Pkh1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002898)/2-activated protein kinases) also contribute to the regulation of endocytosis ([@bib116]; [@bib87]). The [Sur7](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004516) family of proteins is not only implicated in sphingolipid metabolism ([@bib421]), but [Sur7](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004516) was initially found as a suppressor of ***r****vs167* ([@bib342]). Interestingly, [Rvs167](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002796) is the yeast endophilin/amphiphysin homolog and has been directly linked to the scission of invaginated membrane tubules to generate endocytic vesicles (see below). More recently, several endocytic proteins including [Rvs167](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002796) were shown to bind sphingolipids in a high-throughput lipid-binding screen ([@bib125]).

Sphingolipids and ergosterol interact to form subdomains in the plasma membrane of yeast and are genetically and functionally linked ([@bib152]). Ergosterol is the yeast version of cholesterol. The plasma membrane has a 3:1 ratio of ergosterol to phospholipids ([@bib428]); this high level of ergosterol leads to low fluidity/high rigidity of the plasma membrane, restricting the diffusion of transmembrane proteins ([@bib382]). A combination of endocytosis and recycling leads to the polarized localization of some transmembrane proteins, such as the v-SNARE [Snc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000028) ([@bib382]). Recently, it has become clear that ergosterol and its biosynthetic enzymes are clustered in plasma membrane subdomains referred to as membrane compartment of [Can1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000789) (MCCs). When these membrane domains are disrupted, there are global consequences on the structure and organization of the plasma membrane; however, it is currently disputed whether this leads to elevated rates of endocytosis of some cargos or has no effect ([@bib151]; [@bib43]).

Ergosterol was first linked to endocytic functions by the Riezman lab's identification of a mutation in *[ERG2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004815)/[END11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004815)* in a genetic screen for endocytosis mutants ([@bib265]). Ergosterol biosynthetic enzymes that generate a specific sterol ring structure are required for hyperphosphorylation and internalization of [Ste2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001868), presumably via the [Yck1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001177)/2 protein kinases ([@bib267]). However, the deletion of several other *ERG* genes had no effect on internalization of fluid phase or membrane markers and instead slowed their rate of transport through the intracellular endosome/vacuole system ([@bib160]).

### Phosphoinositides: {#s54}

Phosphoinositides are low abundance, highly bioactive lipids in the cytosolic leaflet of cellular membranes. Different hydroxyl groups on the inositol head group of phosphatidylinositol (PtdIns) are phosphorylated by specific lipid kinases at particular organelles. This differential phosphorylation can convey information that, along with sorting signals in cargo, recruits adaptors to initiate formation of a transport vesicle at the appropriate compartment. Lipid phosphatases counteract the kinase activities and promote dissociation of adaptors.

PtdIns(4,5)P~2~ is the most abundant phosphoinositide in the plasma membrane, and early clues that its metabolism might regulate the endocytic machinery came from studies of mammalian systems ([@bib27]; [@bib245]). Subsequently, lipid kinases and phosphatases required for the biosynthesis and metabolism of PtdIns(4,5)P~2~ were also found to contribute to endocytosis in yeast cells ([@bib338]; [@bib17]). In endocytosis, PtdIns(4,5)P~2~ is thought to help localize endocytic machinery to the initiating endocytic site at the plasma membrane. PtdIns(4,5)P~2~ degradation by the yeast synaptojanin-like [Inp51](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001264)/52/53 enzymes in turn mediates the release of that machinery after vesicle scission. However, the altered dynamic behavior of endocytic components in *[inp51](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001264)∆ [inp52](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005050)∆* cells suggests that PtdIns(4,5)P~2~ turnover regulates multiple stages of endocytosis and not just the disassembly stage ([@bib360]). As mentioned above, PtdIns(4,5)P~2~ disrupts yeast profilin-actin interactions ([@bib215]; [@bib139]; [@bib286]) and in other systems weakens interaction between CP and actin-filament ends ([@bib332]). In addition, recent evidence suggests that PtdIns(4,5)P~2~ can relieve [Myo5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004715) autoinhibition, leading to Arp2/3-mediated actin nucleation ([@bib113]). Thus, phosphoinositides in the membrane may directly govern the activities of multiple components of the actin cytoskeleton during endocytosis.

The subcellular localization of specific phosphoinositide species such as PtdIns(4,5)P~2~ is studied using tools such as GFP--PH--PLCδ ([@bib383]). Interestingly, the distribution of this reporter in the plasma membrane originally appeared to be rather uniform; however, more recent TIRFM/2D-deconvolution shows that PtdIns(4,5)P~2~ is actually found in subdomains of the plasma membrane ([@bib356]; [@bib353]), suggesting that specific mechanisms govern the synthesis, degradation, or sequestration of PtdIns(4,5)P~2~ ([@bib226]).

Another intriguing aspect of lipids in promoting endocytosis comes from studies of phospholipid flippases, which facilitate the movement of lipid molecules between the two membrane leaflets ([@bib68]; [@bib108]). [Drs2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000024) and related flippases have been indirectly linked to endocytosis; the [Drs2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000024) chaperone [Cdc50](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000690) is a high-copy suppressor of a temperature-sensitive *[myo3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001612)[myo5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004715)* double mutant ([@bib124]; [@bib255]), and [Drs2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000024) depends upon [Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445) for its correct subcellular localization ([@bib227]). Perhaps most intriguingly, phospholipid flippases may contribute to membrane curvature and budding by promoting bilayer asymmetry ([@bib148]). This is reminiscent of recent discoveries in ER transport vesicle formation, where highly asymmetric cargo was found to promote membrane curvature ([@bib81]). Such a mechanism may explain how budding occurs in cells lacking some *bona fide* membrane remodeling proteins, such as [Rvs161](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000602) and [Rvs167](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002796) (see below), by providing an alternative force to drive membrane deformation and vesicle scission ([@bib201]).

### Proteins that promote vesicle scission: {#s55}

A significant open question is the mechanism(s) by which scission of a membrane bilayer occurs, liberating a vesicle into the cytosol. In animal cells, the key factors implicated in scission are the GTPase dynamin and the BAR domain proteins amphiphysin and endophilin ([@bib55]). The yeast homologs of amphiphysin and endophilin are [Rvs161](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000602) and [Rvs167](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002796), which form a heterodimer ([@bib341]; [@bib117]). As described above for the F-BAR domain of [Syp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000626), BAR domains are dimeric curved structures with a positively charged concave surface that binds to curved membranes ([@bib301]). Some BAR domains also have the capacity to induce curvature by inserting either a helix or a wedge of protein into one leaflet of a membrane bilayer. The [Rvs161](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000602)/167 heterodimer was first implicated in scission when it was observed in *rvs* mutants that ∼20% of the cortical patches that had begun to move into the cytosol then moved back to the plasma membrane instead of separating from the membrane and being internalized as a vesicle; this was referred to as a retraction phenotype ([@bib190]). Further, the Rvs proteins localize to the midpoint of the invagination, consistent with a function at the position where scission occurs.

A second endocytic vesicle scission mechanism that is well studied in animals involves the membrane-binding GTPase dynamin. Dynamin has an oligomerization-stimulated GTPase activity, a membrane-targeting pleckstrin homology domain, and an SH3 domain that recruits a wide range of PRD-containing proteins ([@bib112]). The dynamin oligomer undergoes nucleotide-dependent conformational changes that lead to the scission of the oligomer-wrapped membrane tubule. The closest yeast homolog of dynamin is [Vps1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001709), which is necessary for vesicle formation at the Golgi ([@bib386]), binds to [Rvs167](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002796) and is reported to have a retraction phenotype, suggesting that it facilitates vesicle scission at the plasma membrane during endocytosis ([@bib423]; [@bib346], [@bib347]).

Other recent work has suggested a requirement for actin forces and lipid modifications in scission, since the myosin I proteins [Myo3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001612)/5 and the PtdIns(4,5)-5-phosphatase [Inp52](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005050)/[Sjl2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005050) support the scission function of the Rvs proteins ([@bib201]). [Sla2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005187), interacting with F-actin, also cooperates with the scission machinery ([@bib40]). Thus, while the magnitudes of the contributions of actin, dynamin, and other conserved components to endocytosis may differ between yeast and metazoans, fundamentally the same machinery and mechanisms are utilized.

Uncoating: Regulation of endocytic proteins through phosphorylation {#s56}
-------------------------------------------------------------------

The final stage of endocytosis is the disassembly of the coat; this allows the components to be reused in new rounds of endocytosis and exposes the membrane of the vesicle for fusion with an endosome. The conserved [Ark1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004965)/[Prk1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001357) kinases have been linked to this disassembly activity ([@bib335]), and indeed they appear at endocytic sites during the later stages, when [Abp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000684) and F-actin appear ([@bib426]; [@bib374]). Intriguingly, mammalian cells express related protein kinases that also phosphorylate endocytic components to regulate their activities ([@bib149]; [@bib378]; [@bib78]).

[Prk1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001357) was first discovered as a spontaneous suppressor of a *[pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445)* allele, and [Ark1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004965) was identified as a binding partner of [Sla2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005187) ([@bib80]; [@bib424]). The [Ark1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004965) and [Prk1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001357) kinases appear to be largely redundant in their functions, although there is evidence that they also fulfill some unique roles ([@bib80]; [@bib397]; [@bib5]). A third related protein kinase, [Akl1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000263), is much less well studied. Many endocytic proteins contain multiple copies of the [Prk1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001357) consensus phosphorylation sequence \[L/I/V/M\]xx\[Q/N/T/S\]x**T**G, where there is an absolute requirement for the bolded threonine as the acceptor residue ([@bib424]; [@bib425]; [@bib174]). In *[ark1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004965)∆ [prk1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001357)∆* double-mutant cells, or in cells where the kinase activity is acutely inhibited, large aggregates of membrane, endocytic proteins, and F-actin rapidly accumulate in the cytoplasm ([@bib397]; [@bib335]). These protein kinases disrupt the activities of and/or interactions of specific endocytic components ([@bib397]; [@bib425]; [@bib61]), *e.g.*, interactions between [Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445) and [Sla1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000103), but not [Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445) and [End3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005028) ([@bib425]; [@bib376]; [@bib72]). Phosphorylation of [Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445) is also suggested to influence its ability to interact productively with F-actin and Arp2/3 complex ([@bib375]). Two other factors that affect disassembly of the [Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445) complex are the [Arf3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005620) GTPase-activating proteins [Gts1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003149) and [Lsb5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000539), both of which arrive late to the endocytic coat ([@bib374]). Finally, phosphorylation may play a role in uncoating clathrin, since the yeast auxillin homolog [Swa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002728) implicated in this process is heavily phosphorylated ([@bib123]; [@bib205]).

Phosphorylation of endocytic proteins is counteracted by protein phosphatases, which allow complexes to reassociate and thus participate in new rounds of endocytosis. There is substantial evidence that dephosphorylation of many endocytic proteins is mediated by [Scd5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005856), which serves as an adaptor for the [PP1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000935) protein phosphatase [Glc7](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000935) ([@bib61]; [@bib426]). [Sla1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000103) contains a [Glc7](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000935) binding site that is required for efficient endocytic function and turnover of phosphorylated [Sla1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000103). [Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445) and [Ent1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002320) also have predicted [Glc7](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000935) binding sites ([@bib131]). Recent work shows that [Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445) dephosphorylation and disappearance from patches depends on [Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445) interactions with [End3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005028) and recruitment of [Scd5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005856) ([@bib409]). Thus, there is a critical role for the [Scd5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005856)--[Glc7](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000935) complex in regulating the dynamics and behavior of the endocytic machinery at cortical patches ([@bib72]).

The results above highlight the importance of phosphoregulation in endocytosis, particularly in the final uncoating stage ([@bib335]). Such regulation also facilitates crosstalk between the dynamic protein machinery and the underlying lipid bilayer, *e.g.*, through the PtdIns(4,5)-5-phosphatase [Inp52](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005050)/[Sjl2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005050) and the membrane-binding endocytic factors [Abp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000684) and [Rvs167](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002796) by the kinase [Tor2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001686) ([@bib201]; [@bib368]). Further studies are needed to map the phosphorylation states of other components of the endocytic machinery and thus understand the full extent of phosphoregulation in endocytosis.

Latest Findings, Emerging Views, and Open Questions {#s57}
===================================================

Temporal control of endocytosis {#s58}
-------------------------------

### Ultrastructure of endocytic sites over time: {#s59}

As with many cellular structures that are below the resolution limit of standard light microscopy, it has been challenging to assign precise locations to proteins at endocytic sites and to determine how their spatial patterns change during the rapid steps of membrane invagination and vesicle scission. The two most fruitful approaches have been quantitative immuno-EM and correlative light and electron microscopy (CLEM) ([@bib179]; [@bib208]; [@bib180]). One recent CLEM study concluded that membrane bending begins with actin polymerization ([@bib209]); this seems reasonable given that substantial membrane bending requires forces from actin polymerization, especially given the combination of high turgor pressure and a stiff plasma membrane rich in ergosterol ([@bib26]; [@bib56]). However, a different study using immuno-EM reported that membrane bending preceded the arrival of actin ([@bib180]). These differences highlight a need for continued efforts on this problem.

Another unresolved issue is the orientation of the actin filaments in the developing patch, which requires having ultrastructural information. To date, it has been extremely challenging to perform myosin S1 decoration coupled with EM to define the orientation of filaments in yeast actin structures. However, Mabuchi and colleagues managed to obtain ultrastructures of *S. pombe* actin cables and cytokinetic rings ([@bib193]; [@bib254]), suggesting that with more effort it may be possible to do the same for cortical patches. In the absence of such information for actin patches, models of actin-filament architecture assume that the positions of the NPFs and Arp2/3 complex inform the location of the growing barbed ends. One immuno-EM study reported a marked enrichment of Arp2/3 complex compared to other patch components away from the membrane, which was interpreted to suggest that the growing barbed ends of actin filaments face the base of the invagination ([@bib322]). Consistent with this view, [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707)--GFP was initially reported to localize to the base of the invagination and not move inward with other patch components ([@bib189]). However, more recent studies, one using a [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707)--GFP fusion with the tag in an alternative position and one using immuno-EM, concluded that [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707) does move in with the membrane invagination ([@bib126]; [@bib179]). Thus, the field has not yet reached consensus on the locations of NPFs and hence the orientation of F-actin in the cortical patch. More definitive answers may come when higher-resolution instruments are developed and applied to a carefully vetted set of reagents. Further, we anticipate the need to consider whether some of the reported phenotypes of patch mutants have been partially misinterpreted because deletion or tagging of that component caused (then unrealized) compensatory changes, such as premature arrival or departure of another component.

### Do checkpoints control transitions Between endocytic coats?: {#s60}

Multicolor live imaging of patch components in yeast cells has become an incredibly powerful assay for defining the roles and dynamics of different endocytic proteins and the consequences of mutations or perturbations. And from such approaches, it is now clear that dozens of endocytic proteins are recruited in an ordered sequence, organized as coats. However, what remain unclear are the rules governing the recruitment and progression through each step in this coordinated program. The transition times between some stages are quite regular. For instance, in wild-type cells the gap between the arrival of the middle and late coat is typically very short, although in certain mutants the gap is prolonged and more variable (*e.g.*, [@bib274]; [@bib72]). In contrast, the early-to-middle coat transition is highly variable even in wild-type cells. The source of this variability is not currently known, but may result from a dependence on an increasing local concentration of transmembrane cargo and/or PtdIns(4,5)P~2~. If so, how concentrated must the cargo or lipid become, and how is this sensed? Since the length of time between initiation and the arrival of the middle coat is the most variable of all the endocytic stages, it seems likely to involve some kind of checkpoint. What mechanism could be at work is pure speculation at this point, but thoughts turn to there being a critical level of cargo, or a critical level of cargo interactions with early coat proteins leading to formation of an organized structure with multiple copies of several different proteins.

Unresolved issues in actin network formation and dissolution {#s61}
------------------------------------------------------------

There are also a number of unresolved questions about how actin networks assemble at sites of endocytosis, how the filaments are organized, and how the networks facilitate membrane remodeling. While we know that Arp2/3 complex is the actin nucleator and generates short, branched filaments, we do not know whether all, or even most filaments in a patch are branched. Branches could be rapidly pruned by [GMF](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002470) and cofilin, such that only a fraction of filaments in a patch would be branched at any given point. Further, debranching may occur more robustly in specific regions of a patch, or at specific phases of patch maturation. This remodeling may in turn permit crosslinking proteins such as [Sac6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002536) and [Scp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005894) to organize filaments into parallel or orthogonal arrays, establishing heterogenous filament geometries within a patch. Whatever form the F-actin takes, another open question is whether proteins are free to diffuse within the network, or is the internal environment too dense, making only the outermost shell accessible to cytosolic factors?

Another key question is what restricts the size of the actin network. There is a large enough supply of building blocks (actin, Arp2/3 complex, etc.) in the cytosol to build many actin patches at once, so what factors limit the growth of an individual endocytic site? Is there limiting access to membrane or to active NPFs? A valuable clue in further investigating this process is the observation that *[end3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005028)* and *[sla1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000103)* mutants accumulate fewer but aberrantly large patches ([@bib171]; [@bib30]). A related question is what controls the orientation of polymerization to direct the forces that drive membrane invagination and vesicle scission. Critical to this issue may be the precise locations where each NPF is anchored and/or activated. In this regard, superresolution light microscopy may be very helpful in determining if patches have subdomains enriched or depleted of specific proteins.

There are also important questions left to answer concerning the mechanisms regulating the onset of actin patch assembly, as well as transport and subsequent disassembly of the internalized vesicle/patch. As discussed earlier, it is still unresolved how the first actin filaments are nucleated at an actin patch, *i.e.*, whether there is machinery that activates the Arp2/3 complex for nucleation in the absence of a mother filament, or instead a short mother filament is captured, or if specialized machinery assembles a short "starter" seed (as depicted in [Figure 6](#fig6){ref-type="fig"}). Further, how is [Las17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005707)/WASP activated at the onset of actin network formation? Is [Bzz1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001156) the switch, or is additional machinery involved? How is [Bzz1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001156) recruited to patches at this time, and does it require its F-BAR domain and/or recognition of specific lipids or specific curvature in the membrane? Once vesicles are internalized, how many of them are transported on actin cables, and how are they attached to cables? If a patch moving inward on a cable does not encounter an endosome, does it travel to the back of the mother cell, and if so, what is its fate? Finally, by what mechanisms do internalized vesicles shed their actin coat, and is this a prerequisite for fusion with endosomes?

Alternative pathways for endocytic internalization {#s62}
--------------------------------------------------

Exciting recent evidence demonstrates the existence of an endocytic route that is independent of the canonical clathrin- and Arp2/3-dependent pathway, and instead depends upon [Rho1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006369), the formin [Bni1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005215), and tropomyosin ([Tpm1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005023)), critical factors in actin cable assembly ([@bib312]). Consistent with this finding, evidence for an Arp2/3-independent endocytic route has also been obtained in the pathogenic yeast *Candida albicans* ([@bib104]). Still another recent study has described an alternative endocytic pathway that is evident even after pharmacological interference with actin polymerization by Latrunculin A ([@bib5]). This pathway was found to be dependent on [Abp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000684) and its binding partner [Ark1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004965), but not the related [Prk1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001357) kinase, or several other proteins involved in "canonical" CME. Given the low dose of Latrunculin A used in this study though, and the finding that the Arp2/3-binding A region of [Abp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000684) was required, actin dynamics may still play a role in this pathway. Many questions about these two noncanonical endocytic pathways remain unanswered, including whether they are harnessed to specific cargo or activated by specific environmental conditions. Applying many of the same techniques that have shed so much light on the CME pathway (*e.g.*, live cell imaging of GFP-tagged components and electron microscopy) should allow for a more mechanistic understanding of these alternate pathways.

Comparisons between yeast and mammalian endocytic mechanisms {#s63}
------------------------------------------------------------

A fundamental distinction between CME in yeast *vs.* mammalian cells has been the relative functional importance of clathrin and actin in these two systems. Internalization of CME sites in yeast proceeds even in the absence of clathrin, albeit with significantly reduced efficiency ([@bib190]; [@bib274]), whereas clathrin depletion in mammalian cells arrests CME completely ([@bib261]; [@bib175]). Hence, the current view is that clathrin fulfills a primarily scaffolding/organizational role in yeast, while it mediates a more structural role (in shaping the vesicle) in mammalian cells. In yeast, the requirement for actin polymerization is essential and is believed to contribute the structural role by providing the force for membrane remodeling that opposes the high turgor pressure that exists across the plasma membrane ([@bib4]; [@bib26]; [@bib56]). Further, it has traditionally been thought that there is only a minimal requirement for actin during CME in animal cells. However, recent findings show that the requirement for actin polymerization in animal cell CME can depend on the surrounding environment ([@bib26]). Two types of clathrin structures have been observed in mammalian cells. One is the classic clathrin-coated pit, which forms a spherical clathrin cage structure with an enclosed membrane, leading to internalization even when actin polymerization is blocked ([@bib102]; [@bib229]). The second is referred to as a plaque and is flat and larger than a traditional clathrin pit; these plaques become associated with F-actin as they are internalized ([@bib330]). Actin appears to convert these clathrin scaffolding plaques into internalizing structures, often at locations in cells of high transmembrane pressure or tight contact with other cells or extracellular matrix ([@bib330]; [@bib76]). The extracellular matrix is reminiscent of the yeast cell wall, as is the fact that clathrin is not predicted to form a full spherical cage at yeast endocytic sites based on quantification of clathrin abundance per actin patch in *S. pombe* ([@bib32]; [@bib340]). These observations raise interesting possibilities that require further investigation, including whether there is an analogy to draw between the features of clathrin structures in yeast and the clathrin plaques in mammalian cells. It will be interesting to learn whether the loss of clathrin can be partially tolerated at these sites in mammalian cells as it can be in yeast.

Homeostatic regulation of endocytosis {#s64}
-------------------------------------

### Response to changing environmental conditions: {#s65}

Localization and trafficking of many nutrient permeases and other transmembrane proteins in the plasma membrane are regulated by the concentrations of particular compounds in the media. For example, there tend to be both high- and low-affinity permeases for specific molecules (*e.g.*, methionine, tryptophan, inositol, or uracil), and typically the high-affinity permease is rapidly internalized and degraded when the cells are exposed to high concentrations of the substance ([@bib219]). Similarly, when the metabolic state of the cell changes and cytosolic concentrations of certain compounds are affected (*e.g.*, amino acids or sugars), this can again lead to changes in the residence time and trafficking of particular permeases or transporters ([@bib328]). The general concept of a plasma membrane quality-control system has been proposed, *i.e.*, that there is machinery that detects and removes damaged or misfolded proteins from the plasma membrane, although there is some disagreement on the subject ([@bib220]; [@bib427]). This suggested plasma membrane quality-control system appears to require the activities of the E3 Ub-ligase [Rsp5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000927), much like nutrient-triggered transporter internalization (*Cargo sorting signals and adaptors*), raising the possibility that an intermediate conformation in transporter endocytosis resembles a misfolded protein ([@bib197]). However, there are some differences in terms of what components work together with [Rsp5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000927) to mediate recognition and modification of the substrate, including a recently discovered N-terminal domain in many permeases that directs an apparently novel Rsp5-dependent modification ([@bib197]).

### Response to physiological stress: {#s66}

The normal polarized localization of endocytic actin patches to the bud is also sensitive to stress, *e.g.*, elevated temperature or high salt. In stressed wild-type cells, the polarization is temporarily lost; patches become distributed over the mother and bud surface within 30 min of the shock, but they regain a polarized distribution within 90--120 min ([@bib90]). A common feature of cells with endocytic defects and depolarized actin patches is hyperactivity of cell-wall stress pathways, leading to overly thick cell walls ([@bib366]; [@bib88]; [@bib134]); this supports the view that the endocytic machinery might internalize enzymes involved in cell-wall remodeling ([@bib63]). A number of factors have been implicated in regulating patch redistribution or depolarization, including the cell-wall stress [PKC1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000201)--MAPK pathway and perturbed sphingolipid metabolism ([@bib89]; [@bib22]). For detailed insights into the causes of this depolarization, readers are referred to the article by Howell and Lew in this collection of reviews ([@bib173]).

### Cell cycle and polarity: {#s67}

Cortical actin/endocytic patches have a characteristic distribution pattern in yeast cells, which changes in different stages of mitotic growth ([@bib1]; [@bib10]), suggesting that it is cell-cycle regulated. These distribution patterns are under intense study and are likely to be governed by a combination of inputs that include bud site landmarks, regulatory GTPases that read the landmarks, and other factors such as plasma membrane phospholipids, delivery of secretory cargo by fusion of exocytic vesicles, and feedback loops of signaling pathways ([@bib222]; [@bib211]). Interestingly, this may also involve the morphogenetic checkpoint mediated by [Swe1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003723) kinase, which arrests mitosis in response to defects in actin organization and bud growth ([@bib244]). Recent work in both *C. albicans* and *S. cerevisiae* found evidence for Swe1-dependent phenotypes in endocytosis mutants; combining deletion of *[SWE1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003723)* with a *[sla1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000103)* or *[sla2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005187)* mutation led to an increase in multinucleated cells, indicative of a Swe1-dependent checkpoint acting on (and regulating?) components of the endocytic machinery ([@bib121]). Finally, [Tor2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001686), a member of the cell-cycle-dependent kinase complex TORC2, appears to play a role in controlling the recruitment of endocytic factors [Abp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000684) and [Rvs167](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002796) to facilitate internalization of α-factor receptor ([@bib88]; [@bib368]).

Nuclear functions of endocytic proteins {#s68}
---------------------------------------

It has long been known that several endocytic proteins in mammalian systems undergo nucleocytoplasmic shuttling and can influence transcription ([@bib387]). Thus, it was intriguing to find that several yeast endocytic proteins ([Scd5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005856), [Pan1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001445), [Rsp5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000927), and [Sla1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000103)) likewise spend part of their time in the nucleus ([@bib62]). These studies suggest that endocytic proteins may have other important roles in regulating the assembly and activity of multisubunit complexes in the nucleus and have pointed to possible roles for the karyopherins [Crm1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003450) and [Kap120](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006046) in fluid-phase endocytosis. Additionally, the PtdIns(4)P-5-kinase [Mss4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002616) is found in both the cytosol and the nucleus, but it must localize to the plasma membrane to generate PtdIns(4,5)P~2~ and support viability ([@bib16]). [Bcp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002769) is a nuclear protein that facilitates [Mss4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002616) export from the nucleus to cytosol and restores PtdIns(4,5)P~2~ synthesis, suggesting a possible regulatory cycle between the nuclear and cytosolic/plasma membrane compartments. Given the nucleocytoplasmic shuttling by other endocytic proteins, this regulatory cycle is likely to control more than just the levels of PtdIns(4,5)P~2~.

New approaches for studying yeast endocytosis and actin dynamics {#s69}
----------------------------------------------------------------

The relatively small size of its genome and the availability of extremely powerful genetic tools have made yeast a pioneering model organism for genome-wide high-throughput analyses and have formed the basis for many systems biology approaches. For example, automated techniques allowed for systematic combination of nonlethal mutants into every possible pairwise double mutant followed by phenotypic analysis ([@bib82]). This has expanded to analyzing more subtle phenotypes by combining mutations with strains expressing GFP-tagged proteins and determining effects on protein localization or abundance ([@bib46]). The small number of proteins encoded by the yeast genome have also made it a fertile testing ground for identifying new protein complexes through genome-wide purification of TAP-tagged proteins coupled to mass spectrometry or genome-wide yeast two-hybrid screens and other protein--protein interaction strategies. The strength of analyzing the effects of one or a few mutations on the whole organism carries over into the ability to test the predictions of sophisticated computational modeling.

The innovations described above played an instrumental role in bringing about key discoveries over the past 17 years and will undoubtedly continue to serve as critical tools in addressing open questions about actin and endocytosis over the coming decades. However, it is anticipated that the next wave of advances will also rely on development and application of new tools and instrumentation, as well as new strategies and approaches. Super-resolution light microscopy may enable one to more precisely define the locations of patch proteins and subdomains at endocytic sites. The development of new fast-acting chemical inhibitors that target specific endocytic patch proteins may enable one to acutely arrest patches in specific stages of their maturation and provide new mechanistic insights into the functional roles of each patch component. Moreover, it may be possible to reconstitute some of the steps in endocytosis *in vitro* and to develop single molecule assays to define the activities and interactions of early patch components. Arguably, many of the important advances made in understanding the mechanisms of actin network formation in endocytosis have come from sophisticated biochemical assays and mathematical modeling, which have provided rigorous, quantitative information about each actin regulatory protein. Future advances are likely to require similar assays for the functions of earlier components in the pathway and will enable us to define their order of assembly, affinities, and specific contributions to the process. Ultimately, this anticipated increase in knowledge of the activities, interactions, and regulation of each component of the endocytic patch may enable us to build a complete model for endocytosis and to test experimentally its design principles and gain unprecedented understanding of this biological process.
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